The Regulation of Salmonella Typhi Vi Capsular Antigen Expression in Intestinal Model Epithelia and the Bovine Ligated-Ileal Loop Model by Tran, Quynh Tien-Ngoc
THE REGULATION OF SALMONELLA TYPHI VI CAPSULAR ANTIGEN 
EXPRESSION IN INTESTINAL MODEL EPITHELIA AND THE BOVINE 
LIGATED-ILEAL LOOP MODEL 
 
 
A Dissertation  
 by  
QUYNH TIEN-NGOC TRAN 
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  






Major Subject:  Veterinary Microbiology 
 
 
 THE REGULATION OF SALMONELLA TYPHI VI CAPSULAR ANTIGEN 
EXPRESSION IN INTESTINAL MODEL EPITHELIA AND THE BOVINE 
LIGATED-ILEAL LOOP MODEL 
 
A Dissertation  
by 
QUYNH TIEN-NGOC TRAN 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
 
Approved by: 
Co-Chairs of Committee, L. Garry Adams 
    Andreas J. Bäumler 
Committee Members,  Robert C. Burghardt 
    Reneé M. Tsolis 










The Regulation of Salmonella Typhi Vi Capsular Antigen Expression in Intestinal 
Model Epithelia and the Bovine Ligated-Ileal Loop Model.  (August 2009) 
                        Quynh Tien-Ngoc Tran, B.S., Texas A&M University; 
D.V.M., Texas A&M University 
Co-Chairs of Advisory Committee,  Dr. L. Garry Adams 
         Dr. Andreas J. Bäumler 
 
 Salmonella enterica serovar Typhi, a major public health concern in developing 
countries, continues to be a priority for the World Health Organization.  S. Typhi 
possesses a viaB locus responsible for the biosynthesis of the Vi-capsular antigen, a 
significant virulence factor at the focus of developing improved prophylaxis for typhoid 
fever.  Tissue culture experiments have demonstrated that S. Typhi wild-type capsule-
expressing strain elicits less chemokine secretion than a viaB mutant.  Calf experiments 
using the viaB mutant resulted in an increase inflammatory response.  Osmolarity is one 
of the control signals that affect the biosynthesis of the Vi antigen.  Under high 
osmolarity growth conditions of 300 mM and greater, Vi production is suppressed and S. 
Typhi is highly invasive.  Studies reveal that the viaB mutant displays increased invasion 
towards intestinal epithelial cells.  Our first objective was to implement direct and 
indirect methods to localize and detect Vi expression within intestinal epithelial cells and 
bovine Peyer’s patch.  The second objective was to compare the invasiveness between a 
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viaB mutant, an ompR mutant, and S. Typhi grown under hyperosmolarity.  We also 
measured the effects of these strains in eliciting inflammation in the calf model. 
 We report that tviB was significantly up regulated intracellularly within T84 
polarized cells.  In the calf experiments, tviB was expressed at levels significantly higher 
in calf tissue following invasion compared to inoculum grown under Vi-suppressing 
conditions.  Together, these results support the idea that the Vi capsular antigen is 
expressed after invasion of intestinal epithelial cells in vivo. 
 We found that S. Typhi grown under high osmolarity, the viaB mutant, and the 
ompR mutant had increased invasion in polarized T84 cells and bovine ileal tissue.  Fluid 
accumulation among Vi-deficient and Vi-suppressed strains was similar.  The 
histopathology of the inflammatory lesions of the small intestine produced by the Vi-
deficient and suppressed strains was quite comparable.  Our data supports the notion that 
Vi-suppressed and Vi mutants of S. Typhi exhibit similar levels of increased invasion 
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RT-PCR Real Time-Polymerase Chain Reaction 
DMEM Dulbecco’s Modified Eagle Medium 
LBH 300 mM Sodium Chloride Containing Luria Bertani Broth 
SOB 10 mM Sodium Chloride Containing Luria Bertani Broth 
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egfp Encoding Green Fluorescent Protein 
TLR Toll Like Receptor 
PAMP Pathogen Associated Molecular Pattern 
MHC Major Histocompatibility Complex 
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SPI-1 Salmonella Pathogencity Island 1 
SPI-2 Salmonella Pathogencity Island 2 
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 The organism.  Salmonella Typhi, the etiological agent of typhoid fever, is 
responsible for 16 million cases of human disease and 600,000 deaths worldwide each 
year (68).  This disease is endemic to many developing countries including regions of 
Africa, South America, and Asia.  Children living in endemic areas, travelers to affected 
locations, and microbiological laboratory workers are among those at particularly high 
risk for contracting typhoid fever.  This gram-negative enteric bacillus belongs to the 
family Enterobacteriacea, and it is a motile, facultative anaerobic intracellular pathogen.  
Epidemic recurrences of typhoid fever remain among the most costly human infections 
in terms of both morbidity and mortality (107, 74). 
 
 Transmission.  S. Typhi is transmitted via contaminated water and food and is 
strictly host adapted to humans.  Due to the recent emergence of multidrug-resistant 
strains, the treatment of S. Typhi infection has proven to be difficult and poses a serious 
threat to future treatment options (6, 75, 86, 106).  Infected patients present with a 
history of prolonged fever, headache, abdominal discomfort, and general lethargy.  
____________________ 
This dissertation follows the style of Infection and Immunity. 
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Around 10% of these develop severe or complicated disease and without necessary 
treatment 5-30% of typhoid fever patients may die. 
 
 Pathogenesis: typhoidal versus non-typhoidal salmonellosis.  Experiments 
using the calf model and cultured human cell lines have elucidated some of the 
mechanisms by which S. Typhimurium causes the massive neutrophil influx infiltrate in 
the intestine, which is a pathological hallmark of human non-typhoidal enteritis.  The 
invasion-associated Type III secretion system (T3SS-1), encoded by Salmonella 
pathogenicity island 1 (SPI-1), allows S. Typhimurium to invade intestinal epithelial 
cells in vitro (29, 84).   The mechanisms in which S. Typhimurium and S. Typhi use for 
invasion (26) and for intracellular trafficking are quite similar.  Once S. Typhimurium 
invades, like S. Typhi, it induces membrane ruffling and cytoskeletal rearrangements 
upon contact with HeLa cell surfaces.  Ruffling induced by S. Typhi and S. 
Typhimurium is then accompanied by macropinocytosis and aggregation of cell surface 
class I MHC (26).  Once S. Typhimurium crosses the intestinal epithelial barrier, the 
innate immune system is able to recognize pathogen-associated molecular patterns 
(PAMPS) by toll-like receptors (TLRs) expressed by intestinal epithelial cells.  TLR5, 
which recognizes flagella, appears to be preferentially expressed at the basolateral pole 
of intestinal epithelial cells in vitro (31) and in vivo (12).  The TLR stimulation leads to 
the production of CXC chemokines (e.g. IL-8), which consequently leads to the 
recruitment of a massive neutrophil influx characteristic of gastroenteritis in humans.  
One mechanism by which neutrophils may contribute to diarrhea is related to neutrophil 
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de-granulation and the generation of tissue injury, resulting in damage to the epithelial 
barrier and leakage of extravascular fluids, allowing liquid to flow from blood into the 
intestinal lumen (111).  Both S. Typhi and S. Typhimurium secrete known effectors, 
SipA, SopB, SopD, SopE, that contribute to invasion and inflammation in the host; 
however, SopE2 and SopA are pseudogenes in S. Typhi.  In addition, it has been found 
that the alteration of these effectors do not contribute to the strict host adaptation of S. 
Typhi (83).   
S. Typhi possesses a single, monophasic flagellum (fliC) that has the same 
antigenic specificity whereas S. Typhimurium produces a biphasic (fliCfljB) flagella that 
has two different H antigenic specificities.  The role of flagella is believed to aid in 
motility and is generally associated with the extracellular life of the pathogen. However, 
continuous research is revealing the significance of novel roles of flagella during 
salmonellosis. 
 S. Typhi is highly host adapted to humans and higher nonhuman primates.  Thus, 
there is a lack of animal models suitable to study the molecular mechanisms of this 
pathogen as well as its host-pathogen interactions.  The S. Typhimurium murine model 
of infection is commonly used to study the pathogenic mechanisms of typhoid fever.  S. 
Typhimurium is a zoonotic pathogen that can cause enteritis in a broad host range.  
Upon comparison of the clinical syndromes of typhoidal with those of non-typhoidal 
salmonellosis (caused mainly by S. Typhimurium and other Salmonella enterica 
serovars), significant differences in their pathology and host agent interactions are 
exposed.  First, S. Typhi causes a systemic infection characterized by bacterial 
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colonization of the liver, spleen, bone marrow, mesenteric lymph nodes and Peyer’s 
patches.  The propagation of S. Typhi at systemic locations is believed to occur within 
macrophages and evidence provided by in vitro studies demonstrate that the organism 
survives well in human monocyte derived macrophages and other macrophage cell lines 
(21, 24, 42, 45, 46, 90).  SPI-2 has been shown to be important for the survival of S. 
Typhimurium and S. Typhi in macrophages.  In contrast, S. Typhimurium infection in 
human causes a localized gastroenteritis, while bacteremia only occurs in a small 
percentage of patients (approximately 1%).  Typhoid fever also has a longer incubation 
period (median of 5-9 days) and longer duration of symptoms (fever lasting for 
approximately 3 weeks) when compared to humans infected with non-typhoidal 
salmonellosis.  The incubation period of gastroenteritis caused by S. Typhimurium is 
short (12-72 h) and is followed by a short course of disease (< 10 days), suggesting that 
the infection is successfully cleared by the host’s immune response. 
 Another major difference between typhoid fever and S. Typhimurium-induced 
diarrhea in human is the type of inflammatory response elicited in the intestine.  The 
intestinal pathology observed during S. Typhimurium infection in humans is dominated 
by a massive neutrophil influx in the terminal ileum and proximal colon.  Analysis of 
intestinal biopsies from patients infected with S. Typhimurium reveals an infiltrate 
primarily composed of neutrophils, although mononuclear cells are also present (19, 66).  
Similarly, neutrophils are the predominant cell type (75% fecal leukocytes) in stools 
from patients diagnosed with non-typhoidal salmonellosis (36).  In contrast, typhoid 
fever is not a typical diarrheal disease and biopsies from typhoid fever patients or from 
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volunteers infected with S. Typhi reveal an infiltrate dominated by mononuclear cells 
(53).  Though S. Typhimurium and S. Typhi share similar mechanisms in invading the 
intestinal epithelium, penetration of the intestinal mucosa by S. Typhi does not induce 
IL-8 production from intestinal epithelial cells nor does it trigger the same massive 
neutrophil infiltration seen with S. Typhimurium.  S. Typhi infection does however cause 
the production of IL-6 production due to unclear mechanisms (107).  In addition, 
diarrhea is not a significant sequelae to human infection with S. Typhi, in which diarrhea 
only develops in 1% of typhoid fever patients and only after the onset of fever (44).   
Differences in disease manifestations in humans between S. Typhi and S. Typhimurium 
indicate that S. Typhi possesses distinct virulence factors important in its pathogenesis.   
 
 Animal models of infection.  Our knowledge of the pathogenesis of S. Typhi is 
limited due to the fact that it only infects humans, resulting in the lack of in vivo models 
to study host-pathogen interactions.  The implementation of a variety of cell culture lines 
have elucidated some of the molecular mechanisms in which S. Typhi causes disease; 
however in vivo studies are still warranted in order to validate in vitro findings and to 
promote further understanding of typhoid fever pathogenesis in the host.  Much of our 
information comes from observations in clinical settings, mainly conducted during the 
first half of the 20th century, and in the course of experimental challenge studies in 
healthy adult volunteers carried out in the 1950s and 1960s (44, 60).  Two animal 
models have contributed significantly to our understanding of the human pathogenesis of 
 6
typhoid infection:  oral challenge of chimpanzees with S. Typhi (22, 28) and oral or 
systemic challenge of mice with S. Typhimurium (13, 15).   
 Initial studies conducted at the Walter Reed Army Institute showed that orally 
inoculated chimpanzees with S. Typhi develop a clinical illness that mimicked human 
typhoid fever (22, 28).  The animals experienced a bacteremia, produced fever for 10 
days, and excreted bacteria in their stools.  Differences in clinical typhoid infections 
between chimpanzees and humans included a shorter incubation period followed by a 
milder clinical course of disease in the animal model.  The systemic spread of the 
disease progressed from the primary site of infection, the intestinal lymphoid tissue and 
metastasized to the general lymphatic system and subsequently a circulating bacteremia.  
S. Typhi was found in the liver and spleen, in addition to the bile and gallbladder.  
Pathological examination of lesions present in the intestinal mucosa and lymphoid 
tissue, spleen and liver of infected animals resembled those seen in humans.  
Chimpanzees also had serum antibody and responses to S. Typhi LPS and flagella. 
 The use of higher non-human primates in research has declined in popularity 
overtime due to the expense and public concerns.  Therefore, most studies have relied on 
a murine model of human typhoid that uses S. Typhimurium, which causes a typhoid-
like illness in mice (90).  As a consequence, most of what is known about the 
pathogenicity of S. Typhi has been extrapolated from S. Typhimurium infections in 
mice.  A significant limitation to using this murine model is that S. Typhimurium does 
not cause typhoid fever in humans, but instead causes a localized purulent gastroenteritis 
resulting in diarrhea.   
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Mice infected with S. Typhimurium exhibit systemic disease resembling human 
typhoid fever.  Therefore, the pathogenesis of typhoid fever has been commonly studied 
using S. Typhimurium infection in mice as an animal model.  The intestinal pathology 
caused by S. Typhimurium in mice is similar to that observed in human typhoid fever 
patients and is characterized by edema and mononuclear cell infiltrates of villi which 
become shortened in height (91).  Capillary thrombosis, hemorrhage, and ulcerations 
may be present in the ileum at areas of Peyer’s patches while the epithelium in other 
areas remains largely intact (7, 53, 90, 94).  In susceptible mice, rapid bacterial 
migration to the liver and other internal organs causes death within 6-10 days following 
S. Typhimurium infection (48).  
 More recently, studies have focused on the calf as a model for S. Typhimurium-
induced enterocolitis (89, 98, 99, 110, 112).  Calves develop diarrhea within 12-24 h 
post-ingestion of S. Typhimurium (98).  The infection typically remains localized to the 
intestine and mesenteric lymph nodes (98, 109).  Calves develop a necrotizing 
fibrinopurulent enterocolitis characterized by a severe, diffuse infiltration of 
polymorphonuclear leukocytes (22).  In contrast, mice infected with S. Typhimurium 
develop diffuse moderate mononuclear enteritis in the small intestine characterized by a 
predominantly mononuclear leukocyte infiltrate with no association with diarrhea (91).  
The clinical and pathological features of S. Typhimurium infection in calves parallel the 
disease in man and provide a natural human model of disease.   
 In addition, the use of the calf ligated-ileal loop model has been used to study the 
pathogenesis of S. Typhi (82, 83, 91).  Moreover, the role of the Vi capsular antigen, an 
 8
important virulence factor present in S. Typhi but absent in S. Typhimurium, has been 
shown to reduce inflammation in the calf model and research findings illustrate that the 
model is suitable for studying the effects of Vi antigen expression in vivo (82).  Thus, the 
calf model is a good animal model that allows us to perform comparative studies 
investigating S. Typhi virulence factors that are absent from S. Typhimurium and those 
that may be responsible for allowing S. Typhi to cause typhoid fever in humans. 
 
 Current prophylaxis and treatment.  The Vi capsular polysaccharide of S. 
Typhi is an important virulence factor and protective antigen during its pathogenesis.  
The Vi antigen is believed to block toll-like receptor recognition of pathogen associated 
molecular patterns and allows S. Typhi to go systemic by resisting complement-
mediated phagocytosis.  Immunization with a capsule-containing vaccine has been 
shown to confer protective antibody responses against typhoid fever and is generally 
considered efficacious.  Thus, the Vi capsule is and continues to be a significant focus 
for the development of improved typhoid fever vaccines. 
 Inactivated whole-cell parenteral vaccines have been used previously to prevent 
typhoid fever infections, but the adverse associated reactions have made it unpopular as 
a public health vaccine.  As a result, two vaccines have been developed in the past 
fifteen years and licensed for protection against S. Typhi.  The first one is a parental 
vaccine based on the isolation of a purified Vi capsule polysaccharide from the blood of 
an infected patient.  The second one is a live attenuated oral vaccine derivative of S. 
Typhi Ty21a strain.  
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 Immunization with the capsular polysaccharide vaccine (Typhim Vi) has been 
shown to be effective in its ability to stimulate protective antibody responses against 
typhoid fever (40).  Conversely, inoculation with the vaccine produces some adverse 
side effects.  For example, 17% of adult recipients and 86.7% of children recipients 
experience non-severe and transient local pain at the injection site (40).  The vaccine is 
given subcutaneously at a single dose of 25 µg to persons over 2 years of age, confers 
protection within 7-10 days post-inoculation, and requires 3-year boosters (57, 68). 
 The second licensed typhoid vaccine that is currently available is the S. Typhi 
strain Ty21a live, attenuated oral vaccine (Vivotif).  Ty21a is characterized by a galE 
mutation and its inability to produce the Vi antigen (68).  This mutation is not solely 
responsible for the attenuation of the Ty21a strain since a defined galE and Vi negative 
mutant still maintained some virulence when tested in human volunteers (43).  This 
suggests that the mutations that attenuate Ty21a remain unclear. Hypothetically, a 
problem that may arise with the use of Ty21a is the ability to revert back to a virulence 
form, although no known cases have been reported (67). 
 Similar to the Vi capsular antigen vaccine, Ty21a has been proven to be effective 
and safe in several vaccine trials (8, 16, 57-59, 105).  Ty21 elicits a moderate 
immunogenic response and requires at least 3-4 doses initially (8, 57-59, 72).  Thus, the 
vaccine is usually given at the beginning as three to four bacteria-containing capsules on 
alternate days and requires boosters every five years (68), although a liquid formulation 
of the Ty21a vaccine has been shown to improve the protectiveness (57, 59) .   
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 New generations of typhoid vaccines are being studied and developed to replace 
the current ones due to their drawbacks.  One weakness associated with the use of the 
parenteral vaccine is the greater number of side effects that occur; though the oral 
vaccine may have fewer side effects, it may confer a reduced immunogenicity.  The 
Ty21a strain vaccine offered less protective immunity with the simultaneous 
administration of antimalarial drugs (52).  However, both vaccines are equally effective 
and offer 65% to 75% protection against the disease.  Nevertheless, some of the 
innovative vaccines include a parenteral Vi polysaccharide-protein conjugate that is 
expected to produce higher antibody titers following initial and booster immunizations 
than the Vi vaccine (68) and a number of genetically defined attenuated strains of S. 
Typhi.  Shortfalls in both vaccines and a greater understanding of the genetics of S. 
Typhi virulence and recombinant DNA technology promotes the search for a more 
efficacious and better defined vaccine. 
 
 The Vi (virulence) capsular antigen.  Whole genome sequencing has revealed 
that S. Typhi genome contains 601 genes on 82 genetic islands that are absent from S. 
Typhimurium genome (76).  The largest of these islands termed SPI-7, contains 134 kb 
of S. Typhi-specific DNA and carries biosynthesis genes (viaB locus) for the production 
of the Vi capsular antigen, a linear polymer of α-1,4 2-deoxy-2-N-acetylgalacturonic 
acid variably O-acetylated at the C3 position (38, 41) and the genes encoding Type IVB 
pilus, a structure involved in the invasion of intestinal epithelial cells (113).  The Vi-
antigen is expressed in vitro in macrophages (17, 24) and during human infection, as 
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indicated by the infection of anti-Vi antibodies in patient serum (Widal test) and the fact 
that with vaccination with Vi antigen confers protection against typhoid fever (49, 50, 
62, 85).  Some S. Typhi isolates were reported to lack the ability to express the Vi 
antigen as determined by slide agglutination (3, 87).  However, a prospective analysis of 
clinical S. Typhi isolates for the presence of viaB by polymerase chain reaction (PCR) 
and for Vi expression by a more sensitive technique (i.e. immunofluorescence) found 
that S. Typhi isolates that are Vi-negative by slide agglutination are in fact Vi-positive 
and carry the viaB region (106).   Although the Vi antigen appears to be present in fresh 
clinical isolates, SPI-7 can be lost by deletion upon passage or storage of S. Typhi in the 
laboratory (10, 73).  Most importantly, the role of the Vi antigen during host-pathogen 
interactions is still poorly understood. 
 Recent in vitro observations have revealed that the expression of the Vi capsular 
antigen is regulated by osmolarity.  Under conditions of high osmolarity, as expected in 
the intestinal lumen, the Vi antigen is turned off (78), while flagella and the T3SS-1 
genes are expressed (2).  When S. Typhi wild type is cultured in 300 mM NaCl 
containing Luria-Bertani broth (LBH), the expression of the Vi antigen is suppressed, 
but the secretion of invasion proteins (SipB, SipC, SipA) is increased (114).   
 Under the same conditions, S. Typhi wild type is highly invasive and destructive 
towards epithelial and M cells of rat’s Peyer’s patches (114).  These data suggest that the 
Vi antigen may not be expressed in the intestinal lumen and possibly allow S. Typhi to 
have a more invasive phenotype as it penetrates the intestinal epithelium.  In addition, 
the mechanisms by which Vi expression and invasion are controlled appear to act in 
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opposition to one another.  Infection of polarized human epithelial cells (T84 cells) and 
human macrophage-like cells (THP-1) with a capsulated S. Typhi significantly reduces 
the amount of IL-8 production compared to a non-capsulated mutant (80).  Furthermore, 
these findings support the notion that the Vi antigen may be expressed after invading 
cells and inhibit PAMP recognition by TLRs and resulting in no IL-8 production.  
 The two component positive regulatory systems, RcsBC and OmpR EnvZ, in 
addition to the promoter of the viaB region, located upstream of tviA, have been 
identified as contributors to Vi expression and are modulated by osmolarity.  Under low 
osmolarity conditions, the production of Sip proteins, flagellin, and Vi antigen is 
differentially modulated by the RcsB-RcsC regulatory system.  The transcription of 
iagA, invF, and sipB genes is negatively controlled by the RcsB regulator (2).  The TviA 
protein is not essential for Vi synthesis, but it does function as a positive regulator in co-
transcribing the tviA and tviB genes (37, 104).  When the tviA gene is disrupted, the 
expression of the Vi antigen is strongly decreased.  In addition, the TviA protein may act 
in concert with the RcsB protein at the tviA promoter to activate transcription of the 
genes involved in the Vi synthesis (103).  Hence, the regulations of Vi expression under 
the control of the promoter of tviA and its co-regulatory functions with rcsB have not 
been clearly elucidated.  S. Typhi strains harboring ompR deletions no longer 
agglutinated with Vi anti-serum (78), indicating that somehow the ompR-envZ system is 
involved in the Vi biosynthesis.   Recently, other components of the S. Typhi genome 
have been implicated for involvement with Vi expression.  The type IVB pillus has been 
shown to assist in the invasion of intestinal epithelial cells (113) and evidence suggests 
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that the pilus production and Vi synthesis may be regulated under similar promoters and 
that Vi synthesis precedes pilus production (54).  The rpoS gene, which is a master 
regulator in stress response and required for survival under extreme conditions in S. 
Typhimurium, has been implicated as another regulator of Vi synthesis of S. Typhi (88).
 Polysaccharide capsules are found on the surface of a wide range of gram-
negative bacteria.  Capsules have a significant role in determining access of certain 
molecules to the cell membrane, mediating adherence to surfaces, and increasing 
tolerance of desiccation. Furthermore, capsules of many pathogenic bacteria impair 
phagocytosis (63) and reduce the action of complement-mediated killing.  Consistent 
with this belief, the Vi-antigen was shown to impede uptake of S. Typhi by human 
neutrophils (64).  Thus, the Vi capsular antigen is likely to be major virulence 
determinant of S. Typhi. 
Osmolarity has been shown to be one of the signals that control Vi capsule 
expression in S. Typhi in vitro (2, 78, 114).  S. Typhi grown under hyperosmotic 
conditions in LBH medium suppresses Vi expression where as growing S. Typhi under 
hyposmotic conditions in SOB medium upregulates Vi expression.  This research 
finding corresponds to the different stages of S. Typhi pathogenesis as it encounters 
different osmolarities in vivo.  In the gut lumen, hyperosmotic conditions exist due the 
enzymatic digestion of macromolecular foodstuffs in addition the presence of sodium, 
chloride, and potassium ions in the intestinal fluid.  In tissue and blood, the conditions 
are hypososmotic compared to the intestinal lumen as a result of homeostatic 
mechanisms.  The Vi may be downregulated in the gut, facilitating interactions of S. 
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Typhi with epithelial cells, while it is upregulated in blood, where it is known that Vi is 
important for this stage of infection and in tissue, where it may inhibit TLR recognition.  
Therefore, the central hypothesis of this study is during S. Typhi invasion of intestinal 
epithelial cells, the Vi antigen is downregulated, which enhances the secretion of the 
SPI-1 (T3SS) effector proteins and promotes a more invasive phenotype, possibly 
allowing invasion into deeper tissues.  Following invasion, the Vi is upregulated, 
blocking innate immune recognition of PAMPs.  This theory has been formulated on 
previous studies that expression of the Vi antigen causes decreased levels of pro-
inflammatory cytokine production in human epithelial cells (80) and in the calf ligated 
ileal-loop model (82).   
The second aspect of this study involves the ompR regulator and unraveling its 
role in the expression of the Vi antigen and activation of invasion-associated genes.   
OmpR-Envz, the two-component regulatory system, has been shown to be a positive 
regulator of Vi expression (78), in which the construction of a S. Typhi ompR mutant no 
longer produced the Vi polysaccharide.  Prior studies have shown that a viaB mutant and 
S. Typhi grown under Vi-suppressed secreted increased levels of invasion proteins and 
demonstrated increased invasion (71, 80, 114).  Accordingly, we believe that the ompR 
mutant possesses a hyperinvasive phenotype through the inactivation of Vi expression.  
This would further support the idea that the mechanisms by which Vi expression and 
invasion are controlled appear to act in opposition to one another.  However, currently 
there are no convincing reports of a S. Typhi ompR mutant demonstrating whether or not 
there is an increase invasion associated with this Vi-deficient strain.  As a result, we 
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wanted to test our ompR mutant in the T84 polarized cell experiments and the calf 
ligated loop-model and study invasion. 
In the first set of experiments, we tested the hypothesis that the Vi antigen will be 
upregulated and expressed following invasion of intestinal epithelial cells by infecting 
T84 polarized cells and inoculating calf ligated-ileal loops with S. Typhi and 
demonstrating Vi expression.  We first constructed a gfp fusion to the promoter of the 
viaB region in S. Typhi and determined the fluorescence population between 
intracellular and extracellular bacteria in T84 experiments by using flow cytometry.  We 
performed real-time PCR experiments to analyze Vi capsule expression and invasion 
genes in T84 polarized and the calf ligated-ileal loops.  Ultimately, we directly detected 
the presence of the Vi capsule in calf ileal tissue with fluorescence 
immunocytohistochemistry. 
In the second set of experiments, we tested and compared the ompR mutant, viaB 
mutant, S. Typhi grown under Vi-suppressing conditions, and S. Typhi grown under Vi-
expressing conditions.  We first analyzed the protein secretion profile from the 
supernatant of each strain.  We conducted RT-PCR analysis to study the expression of 
invasion genes associated with each strain.  We infected T84 polarized cells and 
inoculated calf ligated-ileal loops to perform invasion analysis.  Lastly, slides from the 
calf ileal tissue were read and scored according to a scale for inflammatory changes. 
Vi antigen expression has not been studied adequately in different cells lines nor 
has it been examined extensively in animal models.  In addition, the mechanism in 
which the ompR regulon mediates Vi expression and affects invasion remains unclear.  
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Our experiments elucidated how S. Typhi may have adapted to the natural host 
environment and exploited the host environmental niche in order to promote disease in 
humans.  Our results revealed some of the molecular mechanisms of the Vi capsular 





















VI ANTIGEN EXPRESSION IN CULTURED INTESTINAL EPITHELIAL 
CELLS AND BOVINE PEYER’S PATCH 
 
INTRODUCTION  
 Typhoid fever is an acute, systemic infection of the reticuloendothelial system 
caused by Salmonella enterica serotype Typhi, that is annually responsible for an 
estimated 16 million illnesses and 600,000 deaths worldwide (68).  Our knowledge of 
the pathogenesis of S. Typhi is limited because it only infects humans and higher non-
human primates (28), resulting in the absence of in vivo models to study host-pathogen 
interactions.  Many studies have relied on a murine model of human typhoid that uses S. 
enterica serovar Typhimurium, which causes a typhoid-like illness in mice.  As a 
consequence, most of what is known about the pathogenicity of S. Typhi has been 
extrapolated from S. Typhimurium infections in mice.  A significant limitation to using 
the murine model is that S. Typhimurium does not cause typhoid fever in humans, but 
instead causes a localized gastroenteritis resulting in diarrhea. 
 Whole genome sequencing has revealed that S. Typhi genome contains 601 
genes on 82 genetic islands that are absent from the S. Typhimurium genome (76).  The 
largest of these islands termed SPI-7, contains 134 kb of S. Typhi-specific DNA and 
carries biosynthesis genes (viaB locus) for the production of the Vi capsular antigen, a 
linear polymer of α-1,4 2-deoxy-2-N-acetylgalacturonic acid variably O-acetylated at 
the C3 position (38, 41).   The Vi capsular antigen is a significant virulence factor for 
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typhoid fever as strains positive for Vi production have higher rates of infection (43, 44),  
and it continues to be the focus for improvement in current treatment and prophylaxis for 
this disease. 
 The two component positive regulatory systems, RcsBC and OmpR EnvZ, in 
addition to the promoter of the viaB region, located upstream of tviA, have been 
identified as contributors to Vi expression and are modulated by osmolarity.  Under low 
osmolarity conditions, the production of Sip proteins, flagellin, and Vi antigen is 
differentially modulated by the RcsB-RcsC regulatory system.  The transcription of 
iagA, invF, and sipB genes is negatively controlled by the RcsB regulator (2).  The TviA 
protein is not essential for Vi synthesis, but it does function as a positive regulator in co-
transcribing the tviA and tviB genes (37, 104).  In addition, the TviA protein may act in 
concert with the RcsB protein at the tviA promoter to activate transcription of the genes 
involved in the Vi synthesis (103).  S. Typhi strains harboring ompR deletions no longer 
agglutinate with Vi anti-serum (78).  The rpoS gene, which is a master regulator in the 
stress response and required for survival under extreme conditions in S. Typhimurium, 
has been implicated as another regulator of Vi synthesis of S. Typhi (88).  Indeed, 
extensive work has been attempted to characterize the regulation of the Vi expression in 
vitro; however, studies have shown that the gene regulation in infected hosts can 
markedly differ from what has been expected based on in vitro and cell culture work (5, 
55, 56), stressing the need for in vivo studies to understand Salmonella virulence gene 
regulation fully. 
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As S. Typhi encounters different osmolarity environments during its 
pathogenesis, it may in fact possess adaptive responses to these changes (79).  In the 
intestinal lumen, the osmolarity is high, with values considered to be equivalent to 
300mM NaCl and greater (32, 70, 97).  Once S. Typhi invades the intestinal barrier, it 
encounters a lower osmolarity condition equivalent to ~150mM (69), which has been 
reported to be the osmolarity of blood and plasma.  It is thought that the hyperosmotic 
conditions within the intestinal lumen may promote a hyperinvasive phenotype while 
suppressing Vi expression and then following invasion, the Vi is activated and expressed 
whereas the T3SS-1 is down-regulated (81).  
In contrast, other studies have shown that the capsule may inhibit bacterial 
adhesion and invasion of the intestinal epithelium (2, 71), suggesting that the Vi may be 
produced in the intestinal lumen.  Experiments have also demonstrated that natural 
occurring typhoid fever infections as well as live S. Typhi vaccines provoke a poor host 
protective immune response even though the Vi is a good antigen (96), which may be 
due to the inactivation of Vi antigen expression once the pathogen invades the intestinal 
epithelium and resides in macrophages.  This concept has been proposed to be a possible 
explanation for the reduced Vi antibody responses as decreased amounts of antigen may 
be presented to the host’s immune system for processing (78).  However, these 
assumptions are not supported by the current data on Vi capsule expression.  
Nevertheless, the location and the regulation of Vi capsule expression in the host remain 
unclear.  The purpose of this study was to investigate the expression of the Vi antigen in 
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vitro using intestinal model epithelia (polarized T84 cells) and in vivo in the bovine 
ligated-ileal loop model of Salmonella infection. 
 
MATERIALS AND METHODS 
 Bacterial strains and culture conditions.  S. Typhi strain Ty2 was obtained 
from the American Type Tissue Culture Collection (ATCC 19430).  Strains were 
cultured aerobically in Luria-Bertani broth containing 300mM NaCl, (LBH) for optimal 
Vi suppression supplemented with the following antibiotics carbenicillin, 100 mg/L 
and/or kanamycin 100 mg/L, as appropriate.  For T84 cell infection experiments, each 
strain was grown overnight at 37ºC shaking in LBH broth with appropriate antibiotics.  
The next day 1:1000 dilution of overnight culture was made and bacteria were grown 
until OD600= 1.0-1.5 (late log phase) for optimal Vi suppression without antibiotics.  
Bacteria were added at a concentration of 107 cfu/well.  For bovine ligated ileal loops, 
each strain was grown overnight at 37ºC shaking in 4 ml of LBH broth with appropriate 
antibiotics.  A volume of 0.04 ml of overnight culture was used for inoculation of 4 ml 
of LBH broth without antibiotics, and bacteria were grown until OD600= 1.0-1.5 (late log 
phase) for optimal Vi suppression, and the culture was used as the inoculum.  Strains 
were cultured in SOB (Vi-inducing conditions) medium where indicated as controls.  












Table 1.  Strains and plasmids  
 
Strain or plasmid Description Reference and/or 
source 
Strains   
    S. Typhi    
       Ty2 Salmonella Typhi wild type ATCC 19430 
       QT74 Ty2∆ompR::KanR This study 
       QT81 Ty2::pBluescript::egfp::viaB promoter 
region 
This study 
       QT113 Ty2∆ompR carrying pBluescript 
SK+::ompR::KanRCarbR 
This study 
   
Plasmids   
       pcR 2.1 Cloning vector Invitrogen 
       pBluescript SK+ Cloning vector Stratagene 
       pEGFP Green Fluorescent Protein (GFP) 
mut1variant expressing vector 
Clonetech 
       pQT13 pGP704::ompRFR1 This study 
       pQT17 pGP704::ompRFR1::ompRFR2 This study 
       pQT19 pGP704::ompRFR1::ompRFR2::KanR This study 
       pQT27 pEGFP::viaB promoter This study 
       pQT28 pBluescript SK+::egfp::viaB promoter This study 









Construction of a non-polar deletion of ompR in S. Typhi and the 
complementation strain.  A region 1.2 kb upstream of ompR was amplified by PCR 
using FW (5’-GACGGTTCGTGTTCCAGAGCAG-3’) and RV (5’-
CTCTTGCATTGTCTGTACTCC-3’) and a 1.0 kb region downstream of ompR was 
PCR amplified using FW (5’-CGCCGTATGGTGGAAGAAG-3’) and RV (5’-
ACCTGGATGCTGCCTGCCTG-3’).  Both downstream and upstream flanking regions 
were cloned into pCR 2.1 (Invitrogen).  Subsequently, the upstream fragment was 
subcloned into the BglII/SalI site of pgP704, giving rise to pQT13.  The downstream 
fragment was cloned into pQT13 using the XbaI/SmaI site, giving rise to pQT17.  The 
kanamycin cassette (1.5 kb) was excised from pKIXX and inserted in the SalI site in 
pQT17 to give rise to pQT19.  The entire construct was confirmed via nucleotide 
sequencing and restriction enzyme digestion (Figure 1).  Using the suicide plasmid 
pQT19, alleles were introduced into S. Typhi with standard allelic methodologies.  
Colonies were screened for kanamycin resistance and loss of carbenicillin resistance.  A 
general schematic for the generation of QT74 is depicted in Figure 2.   
A single colony, demonstrating loss of carbenicillin resistance and gain of 
kanamycin resistance, was further screened for the ompR deletion.  Loss of the ompR 
gene was confirmed by Southern blotting with an ompR-specific probe, PCR analysis, 
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Figure 1.  Restriction enzyme digestion of pQT19 with SmaI.  Two possible 
orientations:  1st band~6.1 kb and 2nd band~1.15 kb (Lane 4) or 1st band~1.95 kb and 2nd 
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Figure 2.  General schematic illustrating the generation of QT74 (S. Typhi Ty2 ompR 
mutant strain) from allelic exchange methodologies.  E. coli (S17 lambda pir) harboring 
the plasmid construct (pQT118) and S. Typhi Ty2 wild type strain were grown over 
night shaking at 37 degrees C  in appropriate liquid medium.  Following day, 
conjugation experiments involving both strains were performed on LBH plates.  







To generate the complementation strain, ompR was amplified using FW(5’-
TGCCAGCCATCAGCGGGGGCTT-3’) and RV (5’-
GCCCTGATGAATCTCGGTCAG-3’) primers.  The PCR fragment was cloned into 
pBluescript KS+ using EcoRV/EcoR1, creating pQT50.  The plasmid was then 
electroporated into QT74, giving rise to QT113.  The ability of QT113 to agglutinate 
with Vi antisera was restored, indicating the ompR gene was complemented successfully. 
 
Construction of an egfp reporter system encoding the promoter of the viaB 
locus of S. Typhi.  For construction of a Ty2 strain carrying a high copy plasmid 
encoding the viaB region promoter fused to a mutant variant of gfp (i.e. egfp), the 
promoter of the viaB locus was amplified by PCR using the primers FW (5’-
tataccatgggaagtctccttatgctgaaa-3’) and RV (5’-tatagtcgacgcagtcacgcaccatc-3’) flanked 
with restrictions sites SalI and NcoI, respectively.  The resulting 600 bp PCR fragment 
was cloned into pCR2.1 (Invitrogen), and the fragment was confirmed by nucleotide 
sequencing and restriction enzyme digestion (Figure 3).  The fragment was subcloned 
into pEGFP, using the Nco I and Sal I multiple cloning site, giving rise to plasmid 
pQT27.  The promoter of the viaB region and the egfp fragments were excised using SalI 
and EcoRI, and subsequently subcloned into pBluescript SK+ (Strategene), giving rise to 
plasmid pQT28.  A general schematic demonstrating the construction of pQT28 is 
illustrated in Figure 4.  The plasmid was electroporated into Ty2 to produce strain QT81.  
To confirm that Vi expression is modulated by osmolarity in vitro, QT81 was grown in 















Figure 3.  Restriction enzyme digestion of pQT28 with SalI and EcoR1. Band 1~1.36 kb 
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Figure 4.  General schematic illustrating the generation of QT81 (S. Typhi 
Ty2::pBluescript::viaBp:: egfp).  The plasmid construct (pQT28) was electroporated into 
S. Typhi Ty2 wild type electrocompetent cells.  Colonies positive for carrying the 
plasmid were selected on CarbR plates.  Plasmid extraction was subsequently performed 







To confirm the phenotype ompR as a regulator of Vi expression, pQT28 was 
electroporated into QT74, giving rise to QT114.  This strain was grown in different 
osmolarity conditions in broth and subjected flow cytometry analysis. 
 
Cell culture.  T84 cells are a human cell line of colon carcinoma cells that can be 
polarized upon seeding the cells on the apical compartment of Transwell plates and 
adding medium to the basolateral compartment.  Over the duration of a week, the cells 
develop a transepithelial resistance that allows them to mimic the conditions of the 
human intestinal epithelium (shown in Figure 5).  T84 cells were seeded at 5 x 105 cells/ 
well and once they developed a transepithelial resistance of 500-1500Ω (65), bacteria 
were added at approximately 0.418 x 109 cfu/well (multiplicity of infection was 
approximately 10:1) to the apical compartment of polarized T84 cells for 1 hour at 37°C 
in 5% CO2 to allow invasion.  After 1 hour, the supernatant from each well was 
removed.  To compare bacterial gene expression inside and outside mammalian cells, the 
traditional gentamicin approach is not required (9).  Instead, pre-warmed DMEM-F12 
media was added to the apical side and incubated for 2 hours at 37°C in 5% CO2.  After 
the incubation period, the supernatant was collected and extracellular bacteria were 
harvested via centrifugation.  The monolayer was then washed 3 times with ice cold 
PBS.  T84 cells were then harvested and lysed with 1% Triton x-100 and incubated on 
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Figure 5.  Intestinal culture model epithelia: T84 polarized cells. T84 cells were seeded 
at 5 x 105 cells/ well and after 7-10 days, they develop a transepithelial resistance of 500-
1500Ω.  Bacteria were added at approximately 0.418 x 109 cfu/mL (multiplicity of 







Flow cytometry.  Flow cytometry samples were prepared as described 
previously (9).  To characterize QT81 and QT114 in broth, one ml of bacteria culture 
was harvested by centrifugation at 6000x g for 5 minutes.  Bacteria cells were washed 
twice with PBS to remove LB media.  Bacterial pellets were resuspended in 1 ml of 4% 
paraformaldehyde and incubated for 30 minutes at room temperature.  Fluorescence was 
measured by using a FACS Calibur (Becton Dickinson) and the Cell quest software 
provided by the supplier.  The bacterial population was gated by using side and forward 
scatter parameters and then analyzed for fluorescence.  For the analysis of QT81, the 
fluorescence intensities were determined for the number of particles (bacterial cells) as 
follows in culture:  QT81 grown in LBH medium, 87759, QT81 grown in SOB medium, 
73121, and the negative control Ty2 wild type, 62471.  For the analysis of QT114, the 
fluorescence intensities were determined for the number of particles (bacterial cells) as 
follows QT114 grown in LBH, 17640, QT114 grown in SOB, 17583, and Ty2 wild type, 
19413.   
In T84 polarized cell infected with QT81, the flow cytometry results were pooled 
from experimental infections of two separate transwell plates of polarized T84 cells.  
The bacterial population was gated with side and forward scatter parameters using 
samples from the QT81 grown in inducing or low osmolarity (SOB) conditions and 
uninfected T84 polarized cells treated under the same conditions as infected cells in 
order to set the region of fluorescence.  The results are expressed as the percentage 
population fluorescing and the mean fluorescence intensity.  The number of particles 
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used to determine fluorescence intensities were:  extracellular bacteria, 9704 and the 
intracellular bacteria with T84 cell lysates, 49812. 
 
 Bovine ligated-ileal loop model.  Four milk fed 3-4 weeks old calves were 
obtained from a Texas A&M University cattle herd.  Calves were tested for Salmonella 
infection by fecal swabs, enriched in tetraiodothionate broth and plated on XLT4.  
Calves were tested for leukocytosis and fever prior to experiments.  To perform the 
ligated-ileal loop experiments, calves were anesthetized using propofol induction and 
isoflurane maintenance for the duration of the experiment (1).  A right-flank laparotomy 
was performed, the jejunum and ileum exposed and loops with lengths ranging from 6-9 
cm ligated, leaving 1-cm loops between them.  The loops were infected by intralumenal 
injection of a 4 ml suspension containing approximately 1 X 109 CFU/ml of S. Typhi 
strains grown in LBH broth.  Loops injected with LBH broth served as a negative 
control.  Loops were excised at 2 and 8 hours post infection to:  1) collect the fluid that 
has accumulated in the lumen, 2) harvest extracellular bacteria, 6.0 mm biopsy punched 
tissue samples of the mucosa/submucosa for RNA extraction, and 3) collect tissues for 
frozen OCT sections.  The frozen sections were later cut at 10µm thickness for 
fluorescence immunohistochemistry and stored at -80ºC. 
 
 Fluorescence immunocytohistochemistry.  Frozen sections of ileal tissue 
infected with Typhi grown in LBH and loops inoculated with LBH (negative control) 
were fixed in methanol.  Samples were incubated with a primary anti-Vi rabbit antibody 
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(1:250) (Difco) overnight in 4ºC.  Next day, samples were incubated for 2 hours at room 
temperature in a humidified chamber with secondary anti-rabbit conjugated to 
Alexafluor 549 (1:250) (Molecular Probes) in the dark.  All antibodies were diluted in 
antibody dilution buffer (1% BSA in 0.02 M PBS/Tween).  Slides were washed 3 times 
for 10 minutes each in 0.3% Tween/PBS.  A drop of prolong- antifade DAPI solution 
(Invitrogen) was added to each slide.  A coverslip was placed over the top and slides 
were allowed to dry overnight at room temperature.  Next day, slides were stored at 4ºC 
until ready to view.  Samples were observed and photographed with an Olympus IX-70 
camera. 
 
 Real-time PCR.  For analysis of intracellular and extracellular Typhi gene 
expression after one hour post-infection of T84 polarized cells with Typhi wild type, 
extracellular bacteria were collected from the media and T84 cells were lysed with 
Triton X-100 to harvest the intracellular bacteria.  Samples were stored in ethanol/phenol 
mRNA stop solution until RNA was extracted with hot acid phenol/chloroform.  For 
analysis of intracellular and extracellular Typhi gene expression in bovine ileal loop 
infection experiments, extracellular bacteria were harvested from the lumen and kept 
frozen on dry ice and the ileum tissue was kept frozen on dry ice in TriReagent 
(Molecular Research Center) at the site of surgery until further processing for RNA 
extraction.  After RNA extraction from ileal tissue, samples were processed 
subsequently, using the Microbe Enrichment Kit (Ambion) in order to isolate bacterial 
RNA.  All samples prior to Reverse Transcriptase were DNase treated (Ambion DNA-
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free kit).  Subsequently, 1,000 ng of each sample was retrotranscribed in a 50µl volume 
(Taqman reverse transcription reagents; Applied Biosystems) and 4µl of cDNA was 
used for each real time (RT)-PCR.  RT-PCR with primers were used to detect the tviB 
gene in bacterial messenger RNA in order to measure Vi expression and rpoD, the 
internal control gene, in S. Typhi infected T84 polarized cells using SYBR Green 
(Applied Biosystems) and the ABI 7500 Real Time PCR System.  The rpoD gene has 
been shown to have no significant variation of expression in either Typhi or 
Typhimurium inside macrophages (23, 25) and T84 polarized cells (this study).  RNA 
samples were analyzed for prgH and fliC genes to monitor the expression levels of the 
SPI-1 (T3SS) and flagellin, respectively.  For each run, the calculated threshold cycle 
(Ct) was normalized to the Ct of rpoD gene amplified from the corresponding sample, 
and the data were analyzed using the comparative Ct method (Applied Biosystems).  
Levels of Typhi gene expression in T84 polarized cells were calculated relative to the 
inoculum Ty2 wild type grown in LBH.  Levels of Typhi gene expression in calves were 
calculated for each ileal loop infected with Typhi wild type relative to an infected loop 
with Typhi ompR mutant strain (non-producing Vi strain) collected at the same time 
point from the same animal.  A list of genes analyzed in this study with respective 











Table 2.  Primers for Real-time PCR 
























Statistical analysis.  For statistical analysis of ratios (i.e. increases in Typhi gene 
expression or data expressed as percentages), data were transformed logarithmically 
prior to performance of statistical analysis.  A parametric test (paired student’s t-test for 
T84 polarized cell samples and for calf ligated-loop samples) was used to calculate 
whether differences were statistically significant. 
 
RESULTS 
S. Typhi carrying the viaB promoter fused to egfp (enhanced green 
fluorescent protein) on a plasmid grown in different salt concentrations indicates 
that the Vi antigen expression is modulated by osmolarity.  GFP (Green fluorescent 
protein) has been previously applied to study host pathogen interactions and 
salmonellosis gene expression (9, 11, 100, 101).  Here we first wanted to determine 
whether the S. Typhi wild-type isolate Ty2 harboring the viaB region promoter fused to 
egfp on a high-copy plasmid (QT81) would demonstrate that Vi antigen expression is 
modulated by osmolarity and to validate this strain for subsequent T84 polarized cells 
infection experiments, thus we inoculated SOB (Vi-inducing) and LBH (Vi-suppressing) 
medium with this strain.  As a negative control, SOB medium was inoculated with the 
Ty2 wild type.  The bacterial population was gated by using side and forward scatter 
parameters and then analyzed for fluorescence.  The results are expressed as the 
percentage population fluorescing and the mean fluorescence intensity.   
 When QT81 was grown in LBH media (Vi-suppressing) containing carbenicillin 
(100µg/ml) overnight at 37º C shaking, the number of bacterial cells fluorescing and 
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level of fluorescence intensity was comparable to that of the negative control.  When the 
same strain was grown in SOB medium (Vi-inducing) containing carbenicillin 
(100µg/ml) under similar conditions, the majority of cells exhibited fluorescence 
intensity which was increased by 100 times when compared to the negative control and 
the strain grown in LBH medium (Figure 6).  These results agreed with previous reports 
that Vi expression of serotype Typhi is affected by osmolarity (114).  
 
 S. Typhi expresses the Vi capsular antigen at higher levels intracellularly 
within T84 polarized cells.  To further investigate the location of Vi expression in 
intestinal epithelial cells in vitro, we proceeded by infecting T84 polarized intestinal 
epithelial cells with QT81.  We wanted to determine if Vi expression occurred inside 
intestinal epithelial cells by infecting T84 polarized cells with QT81.  The flow 
cytometry results were pooled from experimental infections of two separate transwell 
plates of polarized T84 cells.  The bacterial population was gated with side and forward 
scatter parameters using samples from QT81 grown in inducing or low osmolarity 
(SOB) conditions and uninfected T84 polarized cells treated under the same conditions 
as infected cells in order to set the region of fluorescence.  The results demonstrated that 
a larger percentage of bacteria (53.8%) were expressing fluorescence inside polarized 
T84 cells as opposed to the 22.9% expressed by the extracellular bacteria in the 

















Figure 6.  In vitro induction of serotype Typhi Ty2 carrying pBlueScript 
SK+::ptviA::egfp (QT81).  Thick line represents QT81 grown under inducing conditions: 
low osmolarity (SOB broth).  Thin line represents QT81 grown under non-inducing 
conditions:  high osmolarity (LBH broth).  The shaded area represents Ty2 wild type 
without the reporter plasmid under inducing conditions. The results are expressed as the 
percentage population fluorescing and the mean fluorescence intensity.  The number of 
cells used to determine fluorescence intensity and % GFP positive cells for each sample 
are as follows:  QT81 in LBH, 87759, 28.8%, QT81 in SOB, 73121, 69.2%, and Ty2 wt, 










































Figure 7.  Flow cytometry detection of Vi expression in T84 polarized cells using Typhi 
Ty2 carrying pBlueScript SK+::viaB promoter::egfp. (QT81).  The number of particles 
used to determine fluorescence intensities were:  extracellular bacteria, 9704 and the 







To further examine Vi expression during infection of T84 cells with QT81, we 
performed real-time PCR analysis.  We monitored the expression of tviB and of genes 
encoded by the SPI-1 T3SS-1 (fliC, prgH, and iagA).  T84 polarized cells were 
inoculated with serotype Typhi grown in LBH medium and for each experiment, 
bacterial RNA was pooled from infections of 10 separate transwells.  The invasion 
associated SPI-1 and the genes involved in flagellar biosynthesis were previously shown 
to be upregulated during initial stages of crossing the epithelial cell barrier and down 
regulated following invasion (30, 35, 39).  Levels of serotype Typhi gene expression in 
T84 polarized cells were calculated relative to the inoculum Ty2 wild type grown in Vi-
suppressing medium.  The results from the real-time PCR experiments analyzing the 
expression of S. Typhi Vi capsular antigen, flagellin, and invasion genes revealed that 
tviB was expressed significantly higher (p=0.049) by intracellular bacteria than by 
extracellular bacteria, suggesting that the expression of the Vi biosynthesis genes was 
upregulated after invasion of T84 polarized cells (Figure 8). The fliC gene was expressed 
at higher levels among extracellular bacteria, though this difference was not statistically 
significant. The prgH invasion gene was expressed at significantly higher (p=0.013) 
levels by extracellular bacteria than by intracellular bacteria.  Similarly, the iagA 
regulator was expressed at significantly (p=0.037) higher levels by extracellular bacteria 
compared to intracellular bacteria.  These findings provided evidence that the Vi antigen 
was expressed at lower levels during invasion compared to higher levels observed 
following invasion of epithelial the cells.  The inverse was observed for SPI -1 (T3SS) 
genes, which is in good agreement with previous reports (26, 29).   
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The transcript levels of tviB were expressed as fold increase over those measured 
in the inoculum culture, which was grown under Vi-suppressing and optimal invasion 
conditions.  The increased level of detected tviB expression in extracellular bacteria may 
be an effect of DMEM-F12 media, which possesses an osmolarity of 150 mM.  Thus, the 
low osmolarity cell culture media may be responsible for inducing Vi expression 
extracellularly, as suggested in other studies (39).  This may be a limitation of the T84 
polarized cell culture model in studying Vi expression.  However, growing S. Typhi in 
300 mM NaCl media is known to suppress Vi expression.  S. Typhi grown under those 
conditions produces a weak agglutination reaction with Vi antisera (2, 78), indicating 
that the Vi capsule is expressed at low basal levels. 
 
 The osmolarity of the fluid within calf ligated ileal loops is not hyperosmotic.  
The calf model has been implemented successfully to study the pathogenesis of S. Typhi 
(82, 83).  In order to study the expression of the Vi antigen in vivo, we inoculated calf 
ligated-ileal loops with serotype Typhi grown under high osmolarity (300mM NaCL 
containing LB medium) to mimic the intestinal luminal conditions and to suppress Vi 
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Figure 8.  Profile of bacterial gene expression in extracellular and intracellular bacteria 
harvested from T84 polarized cells infected with serotype Typhi wild type after 1 hour.  
Expression levels of tviB, fliC, prgH, and iagA were determined by real-time PCR.  Data 
are shown as increases of Typhi gene expression relative to the preinoculum grown 






 We first wanted to determine the osmolarity level of the intestinal luminal 
contents at 2 and 8 hours post-infection by measuring the osmolalilty of the luminal fluid 
using Wescor 5100C Vapor Pressure Osmometer according to manufacturer’s 
instructions.  Experimentally only the osmolality can be measured; however the 
approximate osmolarity values can be determined by conversion (95).  A list of 












 8 hr post-
infection 
 Blood/Tissue 150 mM NaCl ~363 (estimated)1 
92.86-101.64 mM 259-275 
99.45-114.26 mM 271-298 2 hr post-
infection 
~105 mM  282 T84 cell media 
10mM NaCl 104SOB  
300 mM NaCl 631LBH  






 1Value was estimated based upon reported osmolarity value of 150 mM NaCl from reference 30. 
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Measurements of the osmolality of the intestinal fluid revealed that at 2 and 8 
hour time points, the intestinal fluid possessed osmolality values of approximately 294 
mmol and 268 mmol, respectively, which corresponded to an osmolarity level of ~150 
mM.  These results agree with previous calf ileal cannula studies in which the ileal fluid 
osmolality was reported to be similar to that of plasma (280-300 mmol) (18, 61).  
Nevertheless, the values obtained in our study indicated hypoosmotic conditions, which 
were predicted to induce Vi expression within the intestinal lumen.  This prediction was 
tested by real-time PCR analysis performed on the extracellular bacteria collected at the 
time indicated points (Figure 9). 
 
Characterization of a nonpolar ompR deletion in S. Typhi Ty2.  A deletion in 
ompR was previously shown to inhibit Vi synthesis and result in a negative Vi slide 
agglutination reaction (78).  A deletion of the ompR gene was constructed in serotype 
Typhi strain Ty2 and the mutation was verified by Southern Blotting (Figure 10A).  The 
inability of the S. Typhi ompR mutant to express the Vi antigen was verified with Vi 
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Figure 9.  Profile of extracellular bacterial gene expression collected from the luminal 
fluid at two and eight hours in the calf ligated ileal loops post-infection.  Data are 
expressed as increases in bacterial mRNA levels relative to loops infected with serotype 
Typhi ompR mutant at the same time point.  Bars represent geometric means ± standard 
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We also constructed a high copy plasmid carrying the whole ompR gene (plasmid 
pQT50) and introduced it into the S. Typhi ompR mutant by electroporation.  Expression 
of the Vi capsular antigen in S. Typhi was restored and confirmed by Vi agglutination 
(Figure 10B).  Complementation with a low copy plasmid (pwsk29) carrying the ompR 
gene did not restore Vi production when detected by slide agglutination.  This finding 
was consistent with prior ompR complementation studies (78).  The ompR mutant strain 
was subsequently used in our calf ligated-ileal loop studies. 
 Vi expression by the ompR mutant was further characterized by introducing 
plasmid pQT28 (carrying a egfp reporter gene fused to the promoter of the viaB region).  
The resulting strain (QT114) was grown in culture in media with different osmolarities 
and egfp expression was analyzed by flow cytometry.  Bacterial cells were gated using 
forward and side scatter parameters.  The fluorescence intensity emitted by the S. Typhi 
Ty2 wild-type grown under non-Vi inducing conditions (negative control) and strain 
QT114 grown under Vi-inducing conditions (SOB broth) were similar (Figure 11).  
QT114 grown in LBH also exhibited similar levels of fluorescence to the Ty2 wild type 
(data not shown).  These data indicated that ompR encoded a positive regulator of the 






















Figure 10.  Characterization of serotype Typhi ompR mutant. (A)  Southern blot with 
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Figure 11. Flow cytometry analysis of QT114 grown under Vi optimal expressing 
conditions (SOB).  Ty2 was used as a negative control. The numbers of cells used to 







The Vi capsule is expressed after invasion of the bovine intestinal 
epithelium.  The mammalian small intestinal lumen has a reported osmolarity of 300 
mM NaCl (~676 mOsm) and greater (47, 69).  However, we detected hypoosmotic 
conditions within the lumen of bovine ileum (Table 3), which has been shown 
previously in calf ileal studies post-treated with hypertonic and isotonic solutions (18, 
61), suggesting that the intestinal lumen is not consistently hyperosmotic.  It has also 
been demonstrated that in the human small intestine, except shortly after eating, the 
luminal content osmolarity is the same as plasma as a function of a normal intestinal 
permeability mechanisms (27). 
Nonetheless, we reasoned that to study increases in bacterial gene expression in 
the tissue, Vi-expression may be compared to that of a S. Typhi culture grown in 300 
mM NaCl broth (Vi-suppressing conditions), the reported osmolarity of intestinal 
contents (47, 69).  In order to illustrate Vi expression, bacterial gene expression for each 
loop inoculated with serotype Typhi wild type was analyzed as log fold increase over the 
S. Typhi ompR mutant, which is deficient for Vi expression, collected at the same time 
point.   
 We performed real-time PCR analysis to investigate the expression of the Vi 
antigen, by monitoring tviB, and genes encoded by SPI-1 T3SS-1 (fliC, prgH, and iagA) 
in calf ileal tissue following invasion at two and eight hours post-infection.  At 2 and 8 
hours, expression of tviB among intracellular bacteria within calf tissue was significantly 
higher than in the inoculum (Figure 12).  All the invasion-associated genes were down 
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regulated in tissue at 2 h, and 8 h when compared to expression levels detected in the 
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Figure 12.  Profile of bacterial gene expression in the preinoculum and bovine ileal tissue infected with 
serotype Typhi wild type determined by Real-time PCR at two and eight hours post infection.  Data are 
expressed as increases in bacterial mRNA levels relative to loops infected with serotype Typhi ompR 
mutant at the same time point.  Bars represent geometric means ± standard deviation.  These data are 
averages from four different bovids.  Statistical significances of differences are provided. 
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We wanted to directly detect Vi production within frozen sections of calf 
intestinal tissue and to identify the location of capsule expression at 2 hours and 8 hours 
post infection.  We first labeled the infected tissue with primary anti-Vi antibody and 
then labeled the tissue with a secondary anti-rabbit goat antibody conjugated to 
Alexafluor 594, which emitted an orange-red emission and the nuclei of cells were 
stained with DAPI.  As a negative control, uninfected intestinal tissue at corresponding 
time points were subjected to similar labeling procedures.  No Vi antigen production was 
detected in the uninfected ileal tissue (Figure 13C and 13F).  Ileal loops infected with S. 
Typhi strain Ty2 grown under Vi-suppressing conditions after 2 hours revealed Vi 
expressing bacteria along the intestinal villi tips where they appeared to penetrate the 
intestinal epithelial barrier and enter the lamina propria (Figure 13A and 13B).  The two 
component regulatory systems, OmpR EnvZ and RcsBC, activate Vi antigen expression 
when S. Typhi encounters decreasing osmolarity in tissue or blood (2, 103).  Thus, our 
findings support the concept that the production of the Vi antigen may occur while 
bacteria pass through the intestinal epithelium.  Fluorescent staining of bovine Peyer’s 
patch sections revealed large numbers of Vi-expressing bacteria in the mantle and in the 
area between germinal centers (Figure 13D and 13E).  Since Peyer’s patch are large 
lymphoid aggregations consisting of both T and B cell areas within the small intestinal 
mucosa, these data suggested that the Vi antigen may be expressed intracellullarly within 
dendritic cells.  Reports suggest that murine Peyer’s patch dendritic cells are important 
in antigen presentation for T-cell proliferation and T-cell help for B-cell responses (92, 






















Figure 13. Fluorescence immunohistochemistry detection of Vi antigen expression in bovine ileal tissue.  
Frozen calf ileal tissue in OCT medium were sectioned at 10μm and primarily stained with anti-Vi rabbit 
antibody and secondarily with goat anti-rabbit antibody conjugated to Alexfluor 549.  Cell nuclei were 























bovine Peyer’s patch when encountering enteropathogens.  At 8 hours, our findings were 
similar but the numbers of invasive bacteria expressing capsule within the tissue were 
elevated.  These findings illustrated that the Vi capsule was expressed following 
invasion of the gut mucosa, which supported a role of the capsule during bacterial host 
cell interaction in tissue.   
 
DISCUSSION 
The expression of the Vi capsular antigen in serotype Typhi infection presents a 
possible explanation for the different clinical manifestations observed in humans 
compared to other serotypes of Salmonella.  There are two major hypotheses on the 
regulation of Vi expression in the intestinal environment.  One theory suggests that the 
Vi is produced in the intestinal lumen and may inhibit bacterial adhesion and invasion of 
intestinal epithelia (2, 71).  The second theory suggests that the Vi is suppressed in the 
lumen and activated following invasion to allow the organism to evade host innate 
immunity (80, 82).  Current research on the regulation of the Vi antigen supports the 
latter hypothesis that the Vi antigen may be expressed after invading nonphagocytic cells 
and following uptake by macrophages.  To further test this hypothesis, we investigated 
the regulation of Vi antigen expression in vivo by performing direct and indirect 
experimental techniques to detect the Vi antigen in intestinal model epithelia (T84 
polarized cells) and in vivo in the bovine ligated- ileal loop model.   
The infection of T84 polarized cells with S. Typhi grown under Vi-suppressing 
conditions and analyzed by flow cytometry and real-time PCR demonstrated that the Vi 
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antigen was expressed at higher levels by intracellular bacteria.  These results, along 
with previous findings that capsulated S. Typhi have a significant reduction in the 
amount of inflammatory cytokine secretion compared to a non-capsulated mutant (42, 
80), support the view that the Vi antigen has a role following invasion of intestinal 
epithelial cells.  Consistent with this concept, our analysis of T3SS-1 gene expression 
with real-time PCR indicated increased transcription in extracellular bacteria and a down 
regulation of these genes after invasion. 
 Studies on the regulatory mechanisms responsible for Vi capsular expression 
revealed that the expression of the biosynthesis genes is regulated by osmolarity.  
Though it is believed that the small intestinal lumen is hyperosmotic due to the influx 
and digestion of foodstuffs and the presence of sodium salts and bile acids, we reported 
that the fluid collected from lumen of the calf ligated-ileal loops at designated time 
points was hypoosmotic, which is considered to be a normal physiological occurrence as 
seen in prior calf ileal cannula studies measuring the osmolality of luminal fluid (61) 
(Table 3). Previous experiments have shown that large variations in osmolality occur 
within the lumen due to the mechanistic effects of the villus countercurrent exchanger, 
which mobilizes water and electrolytes (33, 34).  This counter current exchanger 
maintains the plasma osmolality of the blood and leaves the fluid surrounding the villus 
close to isotonicity, regardless of the lumen osmolality.  As a result, the hypoosmotic 
fluid, which can also be considered isotonic, within the lumen may account for inducing 
Vi expression in the extracellular bacteria (Figure 4).   Nevertheless, these data agree 
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with previous findings and support the concept that Vi expression is regulated by 
osmolarity in vivo.   
 Under conditions of high osmolarity, which are thought to mimic conditions 
encountered in the intestinal lumen, the Vi antigen is suppressed (78), while flagella and 
the T3SS-1 genes are activated (2).  When S. Typhi wild type is cultured in 300 mM 
NaCl containing Luria-Bertani broth (LBH), the expression of the Vi antigen is 
decreased, but the secretion of invasion proteins (SipB, SipC, SipA) are increased (114).  
Under the same growth conditions, S. Typhi wild type is highly invasive and destructive 
towards epithelial and M cells of rat’s Peyer’s patches (114).  These data suggest that the 
Vi antigen may be repressed in the intestinal lumen and possibly allow serotype Typhi to 
express a more invasive phenotype as it penetrates the intestinal epithelium.  Here we 
show that the extracellular bacteria in the lumen of the calf ligated ileal loops expressed 
tviB at significantly higher levels while invasion and flagellin genes (prgH, iagA, fliC) 
were expressed at lower levels in intracellular bacteria when compared to expression 
levels of a serotype Typhi ompR mutant.   
Peyer’s patches are large lymphoid aggregations in the small intestinal mucosa 
that are comprised mainly of T cells, B cells, macrophages, and dendritic cells.  The 
surface epithelium contains M cells that transfer antigen from the lumen into the Peyer’s 
patch.  We directly detected Vi production in the bovine intestinal mucosa by using anti-
Vi antigen antibodies and labeling the antibodies with an orange-red fluorophore.  We 
observed Vi-expressing bacteria during the initial stages of penetration of the intestinal 
epithelium as well as following invasion in the areas of the intestinal villi and Peyer’s 
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patches.  Bacteria entering the patch via M cells are taken up by macrophages and 
presented to T lymphocytes.  Interestingly, the Vi antigen was detected in the dendritic 
cell-rich areas between the germinal centers, which suggest that Vi antigen expression 
occurs within dendritic cells.  These results illustrate the presence of Vi expression in 
vivo, but the exact cell types involved remain unknown.  The Vi capsule has been shown 
to be expressed inside macrophages in vitro (17) and during human infection, as 
indicated by the detection of anti-Vi antibodies in patient serum and the fact that 
vaccinations with the Vi antigen confers protection against typhoid fever (49, 50, 62, 85)  
In addition, CD18-expressing phagocytes have been shown to transport S. Typhimurium 
from the intestine to systemic circulation (106).  Therefore, it is plausible that CD-18 
phagocytes may also be important in systemic pathogenesis of S. Typhi. 
In conclusion, this chapter reports that Vi expression is detected following 
invasion in vivo, in T84 polarized cells and in vivo in the bovine intestinal mucosa.  
Furthermore, we demonstrated that T3SS-1 genes, responsible for mediating invasion, 










VI-SUPPRESSED AND VI-DEFICIENT MUTANT STRAINS OF SALMONELLA 
TYPHI PROMOTE A HYPERINVASIVE PHENOTYPE TOWARDS THE 
BOVINE INTESTINAL MUCOSA 
 
INTRODUCTION 
 Salmonella Typhi causes a severe systemic infection of the reticulendothelial 
system, which is communicable by ingesting contaminated food or water.  Because it is 
solely a human pathogen, there is a lack of suitable animal models available to study the 
disease.  Different cell culture systems and the S. Typhimurium murine model have been 
used extensively to study the pathogenesis of S. Typhi (26, 35, 41, 82, 91).  However, a 
limitation to using cell culture systems is that studies performed in infected hosts can 
markedly differ from what has been expected based on in vitro and cell culture work (5) 
and a consequence to using the murine model is that S. Typhimurium does not cause 
typhoid fever in humans, but instead causes a localized gastroenteritis resulting in 
diarrhea.  Recent studies have successfully used the calf model of enterocolitis to study 
the pathogenic mechanisms of S. Typhimurium (84, 89, 98, 99) and S. Typhi (82, 83).   
 The mechanisms used by S. Typhimurium and S. Typhi for invasion and for 
intracellular trafficking are quite similar (26, 29, 84).  The invasion-associated Type III 
secretion system (T3SS-1), encoded by Salmonella pathogenicity island 1 (SPI-1), 
allows S. Typhimurium to invade intestinal epithelial cells in vitro (26, 29).  Once S. 
Typhimurium invades, like S. Typhi, it induces membrane ruffling and cytoskeletal 
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rearrangements upon contact with HeLa cell surfaces.  Ruffling induced by S. Typhi and 
S. Typhimurium is then accompanied by macropinocytosis and aggregation of cell 
surface class I MHC (26). 
 Nevertheless, the ability for S. Typhi to only infect humans and produce disease 
must mean that there are virulence factors present in S. Typhi but absent in S. 
Typhimurium.  Whole genome sequencing has uncovered that S. Typhi possesses a viaB 
locus encoding region for a linear polymer of α-1,4 2-deoxy-2-N-acetylgalacturonic acid 
variably O-acetylated at the C3 position (10, 40), most notably recognized as the Vi 
capsular antigen.  Studies with the viaB mutant have shown that the presence of the Vi 
capsular antigen of S. Typhi blocks the recognition of pathogen associated molecular 
patterns (PAMPs) and inhibits toll-like receptor (TLR) signaling in intestinal epithelial 
cells (80).  Calf ligated-ileal loop experiments using the viaB mutant resulted in an 
increased inflammatory response, supporting the idea that the viaB region plays a role in 
reducing intestinal inflammation in vivo (82). 
 The growth of S. Typhi in high osmolarity (300 mM NaCl containing LB broth, 
LBH) has been demonstrated to suppress the production of the Vi antigen, but the 
secretion of invasion proteins (SipB, SipC, SipA) are increased (2, 114).  Under the 
same conditions, S. Typhi wild type is highly invasive and destructive towards epithelial 
and M cells of rat’s Peyer’s patches (114).  A viaB mutant has been shown to secrete 
more effector proteins and exhibit increased invasiveness compared to the wild type 
strain using rat ileal loops and the human intestinal epithelial cell line Intestinal 407 (71).  
These findings suggest that Vi deficient and Vi suppressed strains may promote a 
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hyperinvasive phenotype.  The ompR regulon in S. Typhi has been identified as a 
regulator of Vi biosynthesis and that one of its signals for regulation may be osmolarity 
(78).  Furthermore, mutants in ompR have been found to be impaired in virulence, 
preventing them from colonizing epithelial cells in tissue culture (4).  
 Here we compared the invasive characteristics of Vi suppressed and Vi deficient 
mutants of Salmonella Typhi in polarized T84 cells and the bovine ligated ileal loop 
model.  Also, we wanted to investigate whether or not a deleted ompR mutant, that no 
longer agglutinates Vi antisera, would induce similar inflammatory lesions and invasion 
properties as the Salmonella Typhi grown in high osmolarity and the viaB mutant. 
 
MATERIALS AND METHODS 
 Bacterial strains and culture.  S. Typhi strain Ty2 was obtained from the 
American Type Tissue Culture Collection (ATCC 19430).  Strains were cultured 
aerobically in Luria-Bertani broth containing 300mM NaCl, (LBH) for optimal Vi 
suppression supplemented with the following antibiotics:  carbenicillin, 100 mg/L or 
kanamycin 100 mg/L, unless otherwise noted.  For T84 cell infection experiments, each 
strain was grown overnight at 37ºC shaking in LBH broth with appropriate antibiotics.  
The next day 1:1000 dilution of overnight culture was made and bacteria were grown 
until OD600= 1.0-1.5 (late log phase) for optimal Vi suppression without antibiotics.  
Bacteria were added at a concentration of 0.418 x 109 cfu/well.  For bovine ligated ileal 
loops, each strain was grown overnight at 37ºC shaking in 4 ml of LBH broth with 
appropriate antibiotics.  A volume of 0.04 ml of overnight culture was used for 
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inoculation of 4 ml of LBH broth without antibiotics, and bacteria were grown until 
OD600= 1.0-1.5 (late log phase) for optimal Vi suppression.  Subsequently, the culture 
was used as the inoculum, and the numbers of CFU were determined by plating serial 
10-fold dilutions on LB plates.  S. Typhimurium, IR715 is a fully virulent, nalidixic acid 
resistant strain derivative of isolate ATCC 14028 (96).  IR715 was used as a comparator 
for fluid accumulation in bovine ligated loops at 8 hours, as previously done (83, 84).  




Table 4.  Strains used in this study 
Strain Description Reference and/or source 
S. Typhi   
     Ty2 Salmonella Typhi wild type ATCC 19430 
     QT74 Ty2::ompR-::KanR This study 




     STY2 Ty2::∆tviABCDEvexABCDE:: 
KanR 
(Raffatellu, 2005) 
S. Typhimurium   
IR715 Nalidixic acid-resistant 
derivative of bovine wild type 







 Analysis of secreted protein.  The precipitation of bacterial proteins in the 
supernatant of Salmonella growing in culture has been performed previously (84, 85).  In 
brief, bacteria were grown under SPI-1 inducing conditions as described above.  The 
cells were pelleted by centrifugation and 2 ml of the supernatant was collected for each 
sample.  The supernatants were filtered (0.45 µm pore size) and then the proteins were 
precipitated with 0.25% Trichloroacetic acid for 1 hour on ice.  The samples were 
pelleted by high-speed centrifugation (14,000 x g) for 30 minutes.  The pellet was 
washed with cold acetone and resuspended in PBS.  The proteins were then boiled in 
sodium dodecyl sulfate (SDS) for 5 min, and an aliquot of each sample was separated by 
SDS-10% polyacrylamide gel electrophoresis (SDS-PAGE). 
 
 Real-time PCR.  For analysis of Typhi gene expression in culture grown 
bacteria, samples in broth were pelleted and extracted with hot acid phenol/chloroform.  
All samples prior to Reverse Transcriptase were DNase treated (Ambion DNA-free kit).  
Following, 1,000 ng of each sample was retrotranscribed in a 50µl volume (Taqman 
reverse transcription reagents; Applied Biosystems) and 4µl of cDNA was used for each 
real time (RT)-PCR run.  Gene expression was detected using SYBR Green (Applied 
Biosystems) and the ABI 7500 Real Time PCR System.  The rpoD gene has been shown 
to have no significant variation of expression in either Typhi or Typhimurium inside 
macrophages (16, 22).  RNA samples were analyzed for prgH and fliC genes to monitor 
the expression levels of the SP-1 (T3SS) and flagellin, respectively.  For each run, the 
calculated threshold cycle (Ct) was normalized to the Ct of rpoD gene amplified from the 
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corresponding sample and the data were analyzed using the comparative Ct method 
(Applied Biosystems).  Levels of Typhi gene expression were calculated relative to the 
Ty2 wild type grown in LB (Vi expressing conditions).  Primers used in this study are 




Table 5.  Primers used in this study 
 








prgH TCATAATCGCCCCTCGCTAA TCTATGTCGCTGCGCAAAAT 





 Cell culture and invasion assay.  T84 cells are a human cell line of colon 
carcinoma cells that can be polarized upon seeding the cells on the apical compartment 
of Transwell plates and adding medium to the basolateral compartment.  Over the 
duration of a week, the cells develop a transepithelial resistance that allows them to 
mimic the conditions of the human intestinal epithelium.  T84 cells were seeded at 5 x 
105 cells/ well and once they developed a transepithelial resistance of 500-1500Ω (65), 
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bacteria were added at approximately 107 cfu/well (multiplicity of infection was 
approximately 10:1) to the apical compartment of polarized T84 cells for 1 hour at 37°C 
in 5% CO2 to allow invasion.  Invasion assays were performed by using gentamicin 
protection assays described previously (84, 85).  Each well was washed 5 times with 
sterile PBS to remove extracellular bacteria and medium containing 0.1 mg 
gentamicin/ml was added for 90 minutes incubation at 37°C in 5% CO2.  Intracellular 
bacteria were quantified by spreading serial 10-fold dilutions of T84 cell lysates (1% 
Triton x-100) on LB agar plates to determine the number of colony forming units (cfu).  
Invasion results were averaged from infection experiments of 3 separate transwell plates 
of polarized T84 cells. 
 
 Bovine ligated-ileal loop model.  Four milk fed 3-4 weeks old calves were 
obtained from Texas A&M University cattle herd.  Calves were tested for Salmonella 
infection by fecal swabs, enriched in tetraiodothionate broth and plated on XLT4 
(Difco).  Calves were tested for leukocytosis and fever prior to experiments.  Bovine 
ligated ileal loop surgery has been described previously (1, 83).  In brief, the calves were 
fasted 24 hours prior to surgery.  Calves were induced using propofol (Abbott 
Laboratories), followed by placement of an endotracheal tube and then maintained on 
isoflurane (Abbott Laboratories) for the duration of the experiment (1).  A right-flank 
laparotomy was performed, the jejunum and ileum exposed and loops with lengths 
ranging from 6-9 cm ligated, leaving 1-cm loops between them.  The loops were infected 
by intralumenal injection of a 4 ml suspension containing approximately 1 X 109 
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CFU/ml with S. Typhi strains grown in LBH broth.  Loops injected with LBH broth 
served as a negative control.  Loops were replaced into the abdominal cavity until 
collection at 2 and 8 hour time points.  Each bacterial strain was tested in four different 
animals. 
 After surgical removal of the loops, the fluid in accumulated in the loops was 
measured and samples were collected for bacteriology and histopathological analysis.  
The fluid accumulated was normalized to the weight of the tissue (in grams) before 
statistical analysis.  Two 6.0 mm biopsy punches were obtained from intestinal tissue 
and incubated in PBS containing 0.1 mg/liter gentamicin for 90 minutes.  Tissue samples 
were then homogenized in PBS, serially diluted, and plated on LB plates containing 
appropriate antibiotics for determining CFU.  Data on bacterial CFU were normalized to 
the length of the loop and the CFU present in the inoculum prior to statistical analysis.  
 
 Histopathology.  Tissue samples were fixed in formalin, processed according to 
standard procedures for paraffin embedding, sectioned at 5μm, and stained with  
hematoxylin and eosin.  Inflammatory changes were scored from 0 to 5 according to the 
following criteria: 0, no inflammation; 1, mild inflammatory changes characterized by  
multifocal intravascular margination and mild perivascular infiltration of neutrophils in 
the lamina propria and submucosa; 2, mild to moderate inflammatory changes, 
characterized by mild to moderate multifocal to coalescent or diffuse infiltration of 
neutrophils in the lamina propria and submucosa, associated with mild to moderate 
edema; 3, moderate inflammatory changes, characterized by moderate multifocal to 
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coalescent or diffuse infiltration of neutrophils in the lamina propria and submucosa, 
associated with moderate edema; 4, moderate to severe inflammatory changes, 
characterized by mild to severe multifocal to coalescent or diffuse infiltration of 
neutrophils in the lamina propria and submucosa, associated with mild to severe edema; 
and 5, severe inflammatory changes characterized by diffuse severe infiltration of 
neutrophils in the lamina propria and submucosa, associated with severe edema and/or  
multifocal hemorrhage and epithelial erosion.  Slide reading and grading were conducted 
blindly by two boarded veterinary pathologists. 
 
 Statistical analysis.  For statistical analysis of ratios (i.e. increases in Typhi gene 
expression or data expressed as percentages), data were transformed logarithmically 
prior to performance of statistical analysis.  A parametric test (paired student’s t test for 
T84 polarized cell samples and for calf ligated loop samples) was used to calculate 
whether differences were statistically significant. 
 
RESULTS 
 Hypersecretion of invasion proteins in the supernatant of Vi suppressed and 
Vi mutant strains of S. Typhi.  Previous studies have demonstrated that a viaB deleted 
mutant strain secreted greater amount of proteins in the supernatant (71) and Vi-
suppressed S. Typhi grown in LBH broth have a secretion pattern similar to the viaB 
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Figure 14.  Invasion proteins secreted in the supernatant of Vi suppressed and Vi mutant 
strains of S. Typhi.  Lane 1- Ty2 wt grown in LB, 2- Ty2 wt grown in LBH, 3-Ty2 viaB 






supernatant of broth media among S. Typhi Ty2 grown in LB (Vi-expressing), S. Typhi 
Ty2 grown in LBH (Vi-suppressing), QT74, and STY2 (Figure 14).  After growth in 
LBH or LB broth for 4.5 hours, secreted proteins of S. Typhi were collected and 
separated on a 12% SDS-PAGE gel.  A prominent flagellin 52 kDa protein was secreted 
in comparable amounts in all the strains.  However, SipC, a type III invasion associated 
protein, appeared to be secreted the most in STY2.  SipC in both QT74 and Ty2 wild 
type grown under Vi-suppressing conditions seem to be produced at similar levels.  Ty2 
wild type grown in LB broth, in which Vi antigen is expressed, secreted the least amount 
of SipC in the supernatant.  These findings are in agreement with previous studies (114) 
and support the concept that the regulatory mechanisms responsible for Vi antigen 
expression and the expression of the SPI-1 (T3SS) may act paradoxically.  Essentially, 
when the Vi antigen is expressed, the Type III secretion system may be down-regulated; 
whereas when the Vi antigen is suppressed, then the SPI-1 (T3SS) may be up-regulated. 
 
 Invasion associated genes of the T3SS are expressed at relatively higher 
levels in Vi suppressed and Vi mutants grown in culture.  We wanted to confirm that 
the Vi mutants and Typhi wild type grown in LBH would transcribe invasion genes at 
higher levels than Typhi grown in LB.  Regular Luria Bertani broth contains 170 mM 
NaCl and has an osmolarity near that of blood and plasma.  Thus, under this growth 
condition, Vi production is detectable by antisera.  Using Real-time PCR, we found that 
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Figure 15.  Profile of invasion associated genes expressed in Vi suppressed and Vi deficient strains grown 
in culture.  Bacteria were grown in culture to late log phase (OD600=1.0-1.5).  RNA was extracted via hot 
phenol chloroform.  Expression levels of fliC, prgH, and iagA were determined by real-time PCR.  Data 
are shown as increases of gene expression relative to Ty2 wild type grown in Vi expressing conditions 
(LB).  These data are averages from three independent experiments. 
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T3SS-1 and important in invasion tended to be elevated compared to the Typhi Vi 
expressing strain (Figure 15).  The invasion associated SPI-1 and flagellar biosynthetic 
genes were previously shown to be up regulated under high osmolarity conditions in 
recent in vitro studies (2).  In addition, experiments with a viaB deleted mutant also 
revealed increase invasion in cell culture systems (71, 114) and the calf ligated-ileal loop 
model (83), perhaps associated with the inactivation and repression of Vi antigen 
expression when encountering hyperosmotic stimuli.  Our results supported prior 
findings as we also demonstrated that the growth of QT74, STY2, and S. Typhi Ty2 wild 
type grown in LBH medium (Vi-suppressing conditions) tended to express prgH, fliC, 
and iagA at higher levels than S. Typhi Ty2 wild type grown in LB medium (Vi-
expressing conditions), though these data were not found to be statistically significant 
(Figure 15).   
 
S. Typhi cultured in high osmolarity and Vi- deleted mutants are 
hyperinvasive in T84 polarized cells and the bovine intestinal mucosa.  We wanted 
to further investigate the invasiveness of these strains in cell culture as well as an in vivo 
system.  T84 cells are a human colon carcinoma cell line that upon polarization mimic 
the conditions of intestinal epithelial cells (20).  This intestinal model epithelia has been 
used successfully to study invasion of Salmonella (84, 85).  Previous invasion 
experiments have revealed that a viaB mutation introduced in to S. Typhi results in 
increased invasion (83, 114).  To the author’s knowledge, no invasion experiments for 





































ompR mutant wt grown 
in LB          ompR  
complementation
wt grown 
in LBH serotype Typhi viaB mutant 
p=0.172 
Figure 16.  Bacterial invasion of T84 polarized cells after 1 hour of invasion. CFU 
recovered from each experiment was expressed as a percentage of CFU recovered from 
each well relative to the inoculum.  Data are expressed as geometric means (bars) ± 
standard deviations from three independent experiments.  Statistical significance of 
differences between groups is given. 
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performed invasion assay in T84 polarized cells to determine if the ompR mutant 
invaded at a higher percentage than the Vi-expressing wild type and to confirm increased  
invasion among S. Typhi grown under hyperosmotic conditions and the viaB mutant.  
We also used the ompR complementation strain to verify our findings. 
S. Typhi Ty2 wild type grown in LBH medium, QT74, and STY2 (p-value= 
0.032) was recovered in higher numbers from the T84 polarized cells than S. Typhi Ty2 
wild type grown in LB medium (Figure 16).  We used QT113, which introduced the 
ompR gene on a plasmid in QT74.  The results illustrated comparable levels of invasion 
between S. Typhi Ty2 wild type grown in LB and the fully complemented ompR mutant, 
supporting the role of ompR as a negative regulator of S. Typhi invasion. 
Subsequently, we investigated whether the increased invasion associated with 
suppressing Vi antigen expression can also be demonstrated in the calf ileal-loop model.  
We inoculated calf loops with the same strains used in the T84 polarized cell 
experiments:  S. Typhi Ty2 wild type grown in LBH broth, STY2, QT74, and S. Typhi 
Ty2 wild type grown in LB medium, which contains 170 mM NaCl and allows Vi 
expression.  At two hours post-infection, S. Typhi grown under hyperosmotic conditions 
and both of the deleted Vi antigen mutants exhibited significantly higher percentages of 
invasion then S. Typhi grown in LB (Figure 17A).  Next, we wanted to determine if 
there was a difference in invasion between S. Typhi grown in LBH, the ompR mutant 
and viaB mutant.  We found no statistical significance between S. Typhi grown in LBH 




















Figure 17.  Bacterial invasion in bovine ligated ileal loops (A) at 2 hours and (B) at 8 
hours post-infection.  Bacteria was recovered from tissue (6.0 mm biopsy punches) and 
subsequently incubated with gentamicin to kill extracellular bacteria.  CFU recovered 
from each animal was expressed as a percentage of CFU recovered from each loop 
relative to the inoculum.  Data are expressed as geometric means (bars) ± standard 
deviations from experiments performed with four different animals.  Statistical 
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of invasion between the ompR and viaB mutant, the p-value calculated was 0.06, which 
indicates no significance as well.  Therefore, we found no statistical difference in the 
amount of invasion between these groups at the 2 hour time point, revealing that S. 
Typhi grown in LBH and the Vi mutants had similar levels of invasion in bovine ileal 
tissue. 
At 8 hours post-infection, S. Typhi grown in high osmolarity and both of the 
deleted Vi mutants also exhibited significantly higher percentages of invasion then 
Typhi grown in LB (Figure 17B).  We compared S. Typhi grown in LBH, the ompR 
mutant and viaB mutant in invasion at this time point.  There was no statistical 
difference in S. Typhi grown in LBH and the ompR mutant (p= 0.14) and the viaB 
mutant (p=0.56).  Then, we compared the results of invasion between both of the 
mutants, ompR and viaB, the p-value calculated was 0.16, which indicates no 
significance.  Again, we found that there was no statistical difference in the amount of 
invasion between these groups.  Thus, at the 8 hour time point, S. Typhi grown in LBH 
and the Vi mutants also invaded bovine tissue at similar levels. 
We used the Ty2 wild type strain carrying a high copy plasmid carrying the 
whole ompR gene in the calf experiments.  However, this strain was not used in the 
analysis of our calf experiments for the 8 h time point because the number of cfu 
recovered from calf tissue was very minimal, suggesting that over time, the plasmid was 
lost due to instability or lack of selective pressure.  This was confirmed with a growth 
curve in LB without antibiotics and subsequently plating cfu over time on LB plates 
containing carbenicillin (100 µg/ml), to check for the presence of the plasmid.  The 
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optimal time point, in which the number of cfu still retained the plasmid was the highest, 
was at an OD600= 1.2 at 4 hours.  At approximately 6 hours, the number of colonies 
retaining the plasmid dropped dramatically; less than ~ 38 % of the cfu recovered at the 
4 hour time point.  By the 8 hour time point, the numbers recovered were ~11% of the 
amount at the 4 hours time point. 
 
 Vi deficient and suppressed strains of serotype Typhi cause increase fluid 
accumulation in bovine ileal loops.  Bovine ligated-ileal loops were inoculated with S. 
Typhi wild type, viaB mutant, ompR mutant, and LBH as a control loop.  For 
comparative purposes, an LB loop was included to illustrate that LBH would not induce 
considerable osmosis into the lumen and samples were expressed relative to IR715, as 
previously done (81, 85).  Fluid accumulation (a surrogate of diarrhea) is a marker of 
host response in salmonellosis infections.  After 8 hours after infection, fluid amounts 
elicited by each strain were measured.  S. Typhi wild type grown in Vi suppressing 
medium, viaB mutant, and ompR mutant expressed significantly higher (p<0.05) levels 
of fluid accumulation then the LBH control loop.  The viaB mutant has been previously 
shown to produce increase fluid accumulation and cause increase inflammation 
compared to wild type in the calf model.  In this case, we analyzed for statistically 
significant differences in the amount of fluid accumulation between serotype Typhi 
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Figure 18.  Fluid accumulation in the bovine ileum at eight hours post-infection of 
ligated ileal loops with indicated strains of serotype Typhi.  Data are expressed as 
percentages of the response elicited by serotype Typhimurium wild type.  Data on fluid 
accumulation were normalized to the weight of the tissue (in grams).  Bars represent 
geometric means with ± standard deviation.  Asterisks (*) indicate that differences in 
percent fluid accumulation are statistically significant (p<0.05) when compared to LBH 
control loop.  These data are averages from four different bovids. 
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serotype Typhi grown in high osmolarity was not significantly higher (p=0.11) than the 
ompR mutant grown in LBH.  Typhi grown in LBH was not significantly higher  
 (p=0.17) than the viaB mutant grown in LBH.  In comparing the ompR and viaB mutant, 
the amount of fluid was not statistically different (p=0.79).  Interestingly, when 
performing the student’s t-test to compare the strains with serotype Typhimurium, there 
was no statistically significant difference in the amount of fluid accumulated as well.  
Together, these data support the idea that the level of host response correlates with the 
lack of Vi expression.   
 
Histopathology of bovine ileal tissue reveals increased inflammation 
amongst non-expressing Vi capsular strains compared to Vi expressing wild type. 
Gross pathological sections were observed at both 2 and 8 hour time points for bovine 
ligated-ileal loops inoculated with S. Typhi Ty2 wild type grown in LBH, S. Typhi Ty2 
wild type grown in LB, STY2, QT74, S. Typhimurium IR715 wild type, or with sterile 
LBH broth.  Histopathological changes in the bovine ileum in response to infection were 
graded blindly by two board certified veterinary pathologists based on a scale from 1 to 
5, as mentioned in the material and methods section at both two hour and eight hour time 
points.  However, more pathological changes were observed at the eight-hour time point.  
Therefore, pathology scores were determined based on changes for the eight-hour time 
point.  The average pathological scores assigned for each strain at the 8 hour time point 
were:  4.5, 2.5, 4.8, 4.5, 4.9, and 1, respectively. 
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Sections of ileum infected with S. Typhi Ty2 wild type grown in LBH revealed moderate 
to severe changes in the epithelium, characterized by epithelial detachment, blunting and 
erosion, which agrees with previous studies that demonstrate the induction of invasion 
genes and the destruction of the intestinal epithelium with S. Typhi under high 
osmolarity growth conditions (114).  Only mild increases in neutrophilic counts were 
detected in the lamina propria and submucosa of the ileum whereas the numbers of 
macrophages were markedly increased (Table 6 and 7).  Sections of bovine Peyer’s 
patches illustrated mild to moderate increases in neutrophil and moderate mononuclear 
cell counts.  Our pathological findings were similar to previous S. Typhi cultured in 







Table 6.  Histologic changes of calf ileal loops infected with S. Typhi Ty2 wild type 













1 0   erosion 
 
1  blunting 1 1 1 Some dilated 
lacteals 
2 0   erosion 1  blunting 1-2 1 1 Some luminal 
necrotic debris 
3 0   erosion 1  blunting 1 1 1 None 












Table 7.  Histologic changes of calf ileal loops infected with S. Typhi Ty2 wild type 













1 2  erosion 
2 exocytosis 




2 1 erosion 2-3 blunting 
2 crypt    
   abscessation 
2 1 1 Some luminal 
necrotic debris, 
neutrophils, fibrin 




2 early crypt  
   abscessatiom 




4 4 erosion 4 blunting 
2 crypt 
   abscessation 













 Histopathological analysis of ileum infected with S. Typhi Ty2 wild type grown 
in LB revealed normal contracted intact epithelium with a mild increase in neutrophils 
(Table 8 and 9).    The lack of infiltrating neutrophils and the presence of a predominate 
mononuclear cell infiltrate within the intestine is characteristic of typhoid fever 








Table 8.  Histologic changes of calf ileal loops infected with S. Typhi Ty2 grown in LB 
at 2 hours 
 









1 1   erosion 2 blunting 2 2 1 None 
2 1   erosion 2 blunting 2 1 1 Neutrophils in 
lacteals 
3 1   erosion 2 blunting 2 2 1 None 
















Table 9.  Histologic changes of calf ileal loops infected with S. Typhi Ty2 grown in LB 
at 8 hours 
 













2 2   erosion 1   blunting 2 2 1 Some luminal 
necrotic debris 
3 1   erosion 1   blunting 2 2 1 Some luminal 
necrotic debris 








 Sections of ileal loops inoculated with STY2 demonstrated moderate to severe 
changes in the epithelium infrastructure characterized by blunting and fusion of the 
epithelium (Table 10 and 11).  There was a loss of glandular structures along with a 
predominant neutrophil infiltrate in the lamina propria with signs of early crypt abscess 
development.  Large numbers of neutrophils were also present within the interstitium of 
lymphoid follicles (Peyer’s patch).  Our results confirm previous data in bovine ligated-
ileal loops, in which the viaB mutant induced more inflammatory changes when 
compared to the wild type (83).  In rat ligated-ileal loop experiments infected with a Vi-
deficient strain (GIFU10007-3), similar morphological destructive changes in intestinal 









Table 10.  Histologic changes of calf ileal loops infected with S. Typhi Ty2 ∆viaB at 2 
hours 
 









1 0   erosion 0-1 blunting 1 1 1 Some dilated 
lacteals 
2 0   erosion 1   blunting 1 1 1 Some luminal 
necrotic debris, 
neutrophils, fibrin 




2  blunting 
0-1 2 1 None 
















































   abscessation 
3 2 1 Pseudomembrane 
formation 
2 2 erosion 




2 crypt  
   abscessation 
2 2 1 Pseudomembrane 
formation 
3 3-4 erosion 4 blunting 
2 early crypt 
   abscessation 
1 2-3 1 Pseudomembrane 
formation 
4 2 erosion 2-3 blunting 
1 crypt  
   abscessation 














 To the author’s knowledge, no previous experiments have been conducted to 
examine the intestinal pathology induced by an ompR deletion, a possible positive 
regulator for Vi antigen expression and negative regulator for invasion of S. Typhi.  Calf 
ligated-ileal loops were inoculated with QT74, an ompR mutant we generated in this 
study.  After two and eight hours of infection, the intestinal epithelium displayed 
moderate blunting and fusion of the intestinal epithelium along with a predominant 
neutrophil infiltrate within the lamina propria (Table 12 and 13).  Fibrin and neutrophils 
were present within the intestinal lumen (pseudomembranous formation).  There were 
signs of early crypt abscess formation and submucosal edema.  Multiple sections 
revealed engorgement of blood vessels with neutrophils as well as rod-shaped bacteria 
inside neutrophils, as a result of phagocytosis.  The lack of Vi antigen production and the 
activation of the invasion-associated genes have been previously reported (2, 79, 104, 
114).  This provides a possible explanation for the inflammation and subsequent 













Table 12.  Histologic changes of calf ileal loops infected with S. Typhi Ty2 ∆ompR  













1 1 erosion 
1 exocytosis 
1  blunting 2-3 2 1 Reactive 
endothelium  
and margination 
of neutrophils in 
arterioles 
2 1  erosion 1 blunting 1-2  1 1 None 
3 3  erosion 3 blunting 1 2 1 None 














































1 2 erosion 
2 exocytosis 
2-3 blunting 
3 crypt  
abscessation 
3 2-3 1 Pseudomembrane 
formation 
2 2 erosion 2-3 blunting 
2 crypt 
abscessation 
2-3 2 1 Bacterial emboli 
Pseudomembrane 
formation 
3 2-3 erosion 2-3 blunting 
2 crypt 
abscessation 
2 2-3 1 
 
Bacteria in deep 
submucosa 
4 2 erosion 2 blunting 
2 crypt  
abscessation 



















 Studies infecting bovine ligated ileal loops with S. Typhimurium IR715 wild 
type, an in vivo model for human gastroenteritis, have previously demonstrated the 
inflammatory deleterious effects on gut tissue (27, 91).  Results from inoculating calf 
ligated-ileal loops with IR715 served as our positive control in these studies for host 
inflammatory changes.  Sections of ileum illustrated blunting and fusion of the intestinal 
epithelium with a predominant neutrophil infiltrate in the lamina propria as neutrophils 
marginated from the vascular supply into tissue (Table 14 and 15).  There were also 
signs of submucosal edema, congested lymphatics, and necrosis.  All these finding were 




Table 14.  Histologic changes of calf ileal loops infected with S. Typhimurium IR715 













1 4 erosion 
3 exocytosis 
3  blunting 3-4 2 1 Margination of 
neutrophils in 
arterioles 
2 3  erosion 3 blunting 3  2 1 Early crypt 
abscess 
formation 
3 3  erosion 3 blunting 4 2 1 Margination of 
neutrophils in 
arterioles 

















Table 15.  Histologic changes of calf ileal loops infected with S. Typhimurium IR715 













1 4 erosion 
3 exocytosis 
3 blunting 3-4 2 1 Margination of 
neutrophils in 
arterioles 
2 4  erosion 3 blunting 4  2 1 Crypt abscess 
formation 
3 4  erosion 3 blunting 4 2 1 Crypt abscess 
formation 















Negative control loops inoculated with LBH broth had no significant 
pathological findings.  Most sections revealed submucosal edema with a normal intact 




















1 0  erosion 0 blunting 1-2 1 1 None 
2 0  erosion 0 blunting 1-2 1 1 None 
3 0  erosion 1 blunting 1 2 1 None 





















1 0 erosion 0 blunting 1 1 1 None 
2 0 erosion 0 blunting 1 1 1 None 
3 0 erosion 0 blunting 1 1 1 None 







 The Vi capsular antigen of S. Typhi is a significant virulence factor important in 
the pathogenesis of typhoid fever.  Studies have shown that the Vi capsule may exhibit 
anti-inflammatory effects (81, 83).  Much focus has recently been placed on studying the 
regulators and environmental conditions that modulate the Vi antigen expression.  
Expression of the Vi antigen is controlled by the viaA and viaB chromosomal loci (37).  
In vitro studies have demonstrated that the infection of T84 polarized cells with a viaB 
mutant of S. Typhi causes an increase in IL-8 levels compared to infection with S. Typhi 
wild type, suggesting that the presence of the capsule causes decreased inflammatory 
cytokine production (81).  ompR and tviA are two genes that are located on the viaB 
locus.  Another gene, rcsB, located on the viaA locus is thought to act as a positive 
regulator of Vi expression through tviA (105).  More recently, the rpoS gene, a master 
regulator in the general stress response and required for survival under extreme stress 
conditions and for virulence in S. Typhimurium, has been reported to act as another 
regulator of Vi polysaccharide synthesis (88). 
 In this study, our main goal was to examine the role of the ompR regulon in vitro 
with T84 polarized cells, an intestinal culture model system that has not been used 
extensively to study S. Typhi and the bovine ligated ileal loop model, an animal model 
that has been successfully implemented to S. Typhi pathogenesis (81, 84).   
 The involvement of the S. Typhi ompR gene in regulating the biosynthesis of the 
Vi capsule has been previously demonstrated, and it has been suggested that this 
regulation may be responsive to osmolarity environmental signals (78).  However, the 
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function of ompR during invasion of S. Typhi remains unclear.  In Shigella flexneri, 
ompR mutants were shown to be defective in their ability to invade epithelial cells (4).  
The evaluation of the  invasion properties of a S. Typhi ompR mutant have been reported 
in one study to not impair the ability of invasion of epithelial cells, but does not divulge 
any data indicating increased levels of invasion  (78).  Currently, experimental studies 
are underway to evaluate the current hypothesis that the lack of Vi antigen production 
may up-regulate the expression of the T3SS-1 invasion genes and cause hyperinvasion 
among these strains.  Studies have shown that Vi-deficient strains and Vi-suppressed 
strains result in increased invasion compared to the wild type and destruction to murine 
Peyer’s patches (71, 114).  Our results from performing the invasion assay in T84 
polarized cells showed increase invasion among Vi-suppressed strains and Vi-deficient 
strains, including a S. Typhi ompR mutant we constructed, compared to the wild type Vi-
expressing strain.  Using the same strains and inoculating them into bovine ligated-ileal 
loops, we also recovered higher bacterial numbers among the Vi-lacking strains.  
Histopathological examination of infected bovine ileal tissue with Vi mutant strains 
revealed moderate to severe inflammation along with high neutrophilic infiltration.   
Our other experimental results pertaining to the hypersecretion of invasion-
associated proteins in the supernatant of culture medium agree with previous studies 
(114).  Our protein expression analysis revealed that the ompR mutant secretes 
moderately increased levels of flagellin and SipC.  Real-time PCR analysis of invasion 
genes in different osmolarity growth conditions and among different Vi regulator 
mutants also supports the increased invasion theory when repressing or inactivating Vi 
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expression.  Fluid accumulation in the intestinal (a surrogate of diarrhea) is a valid 
measurement of the host inflammatory response induced by each bacterial strain (111).  
The measured fluid collected in the bovine intestinal lumen at 8 hours revealed that the 
ompR deletion mutant results in similar levels of inflammation to S. Typhi grown in 
LBH and the viaB deletion mutant.  Thus, it is logical to propose based on previous data 
and our findings that deleting the ompR gene in S. Typhi, which inhibits Vi capsule 
production, may subsequently up-regulate the SPI-1 (T3SS-1) invasion genes, resulting 
in equivalent invasion and damaging effects to the intestinal epithelium.   
 Possible explanation for any differences in invasion analysis results may be a 
consequence of laboratory techniques, including bacterial growth conditions; inoculation 
at different growth phases; inoculum size; and inoculum composition used.  Divergent 
findings in the interaction between Salmonella invasion and murine Peyer’ patch has 
been reported (14, 51, 77).  Clark demonstrated that the infection of murine ileal-ligated 
loops with S. Typhimurium results in M cells damage and follicular-associated 
epithelium dependent upon inoculum composition (14).  Our T84 infection (65, 80) and 
bovine ligated ileal-loop experiments (82, 84) were conducted based on previous 
methodology.  In brief, our strains were grown overnight at 37ºC shaking in appropriate 
broth, LB or LBH medium with or without appropriate antibiotics.  The next day 1:1000 
dilution of overnight culture was made and bacteria were grown until OD600= 1.0-1.5 
(late log phase) for optimal Vi suppression without antibiotics.  Subsequently, the 
culture was used as the inoculum, and the numbers of CFU were determined by plating 
serial 10-fold dilutions on LB plates. 
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 In conclusion, our data confirm the concept that the Vi polysaccharide of S. 
Typhi behaves as a negative regulator in the invasion process under hyperosmotic 
growth conditions, which is proposed to mimic the conditions of the intestinal lumen in 
mammals.  This is further supported by increased invasion demonstrated among Vi 
regulator mutants in this investigation and others.  The Vi-suppressed S. Typhi is similar 
to the Vi-deficient mutants in its increased invasiveness in T84 polarized cells bovine 


















SUMMARY AND CONCLUSIONS 
 
 Typhoid fever is an acute, systemic infection of the reticuloendothelial system 
caused by Salmonella enterica serovar Typhi, which is responsible for an estimated 16 
million illnesses and 600,000 deaths worldwide, annually (68).  S. Typhi is highly host 
adapted to humans and higher nonhuman primates.  Thus, there is a lack of animal 
models suitable to study the molecular mechanisms of this pathogen as well as its host-
pathogen interactions.  The pathogenesis of typhoid fever is commonly studied using 
Salmonella enterica serovar Typhimurium infection in mice as an animal model.  The 
intestinal pathology caused by S. Typhimurium in mice resembles that of typhoid fever 
patients.  However, human infection with S. Typhimurium causes a localized 
enterocolitis with a massive neutrophil influx and subsequent diarrhea.  Differences in 
disease manifestations in humans between S. Typhi and S. Typhimurium indicate that S. 
Typhi possesses distinct virulence factors important in its pathogenesis.  The calf model 
has been used previously to study the pathogenic mechanisms of typhoidal salmonellosis 
(82, 83).  Thus, the calf model is a good animal model that allows us to perform 
comparative studies investigating S. Typhi virulence factors that are absent from S. 
Typhimurium and those that may be responsible for allowing S. Typhi to cause typhoid 
fever in humans.   
 S. Typhi possesses an important virulence factor, recognized as the Vi antigen, 
which is not present in the S. Typhimurium genome.  Current preventative typhoid fever 
 93
vaccines are formulated based on the polysaccharide capsule and confer a 65-75% 
protective immunity.  Previous studies demonstrated that a non-capsulated S. Typhi 
produces a stereotypic inflammatory host response resulting in CXC IL-8 secretion and 
neutrophilic infiltration, resembling the inflammatory cascade elicited by S. 
Typhimurium (80, 82).  The results from these experiments suggest that the Vi capsular 
antigen may be responsible for preventing the host innate immune response in the 
intestinal mucosa.  The lack of inflammation seen with typhoidal salmonellosis also 
raises the possibility that the Vi antigen may exhibit properties of an anti-inflammatory 
drug.  However, Vi polysaccharide expression in response to the intestinal 
environmental stimuli and the regulators involved in its biosynthesis and export has not 
been examined extensively in cell culture models or in a suitable animal model.   
Therefore, the goal of these studies was to unravel the mechanisms of Vi capsule 
expression and to understand the function of the regulators that modulate its expression 
using human colonic epithelial cells and the bovine ligated-ileal loop model. 
In the first chapter, we implemented direct and indirect methods to localize and 
detect Vi antigen expression within intestinal epithelial cells using T84 polarized cells 
and the bovine ligated-ileal loop model.  We reported that tviB, a gene necessary for Vi 
production in S. Typhi, was significantly up-regulated intracellularly within T84 
polarized cells using real-time PCR.  Infection experiments conducted in the same cell 
line with a S. Typhi carrying a gfp-expressing plasmid fused to the viaB promoter, 
revealed relatively increased numbers of intracellular Vi-expressing bacteria compared 
to the numbers of extracellular bacteria using flow cytometry analysis.  These findings 
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help support our hypothesis that the Vi antigen is up-regulated following invasion of 
intestinal epithelial cells.  Along with previous data showing a viaB mutant eliciting 
decreased levels of IL-8 production in human epithelial cells (82), it provides evidence 
that the location of Vi expression may in fact serve to prevent TLR recognition.   
To determine whether this occurred in vivo, we inoculated calf ligated ileal loops 
and studied Vi gene expression with real-time PCR and detected Vi production via 
fluorescence immunohistochemistry.  Again, we discovered that tviB was expressed at 
levels significantly higher in calf tissue after invasion compared to the inoculum grown 
under Vi-suppressing conditions.  The presence of the Vi capsular antigen was detected 
in bacteria along the intestinal villi tips where they appeared to penetrate the intestinal 
epithelial barrier and enter the lamina propia.  The expression of the Vi capsule along the 
tips of the villi and essentially in the lumen may be a result of the hypoosmotic stimuli of 
the luminal fluid since it is has been shown that Vi is expressed under hypoosmotic 
growth conditions (78, 103).  On the other hand, it may be that the Vi capsule is 
expressed in the lumen, which would be in support of other research findings that 
indicate the capsule may reduce bacterial adhesion and invasion of intestinal epithelium 
(2, 71).  This explanation, however, is not supported by the majority of the current 
studies on capsule expression.  Thus, the reason for Vi expression detected at the tips of 
the villi remains unclear.  
The detection of Vi production in the area of the lamina propria does suggest that 
the Vi may function in masking innate immune recognition in the lamina propria since 
the location of TLRs have been identified on the basolateral pole of intestinal epithelial 
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cells (31).  Additionally, the lamina propria contains numerous phagocytes that express a 
wide range of PAMP receptors on their surfaces.  Fluorescent staining of bovine Peyer’s 
patch sections revealed large numbers of Vi-expressing bacteria in the mantle and in the 
area between germinal centers.  Since Peyer’s patch are large lymphoid aggregations 
consisting of both T and B cells areas within the small intestinal mucosa, these data 
suggested that Vi antigen may be expressed intracellularly with dendritic cells.  The 
dendritic cells may function in antigen presentation for T cell- proliferation and T-cell 
help for B-cell responses.  The Vi capsule has been shown to be expressed inside 
macrophages in vitro (17) and during human infection.  In addition, CD18-expressing 
phagocytes have been previously shown to be important in the dissemination of S. 
Typhimurium infection (102), so it is possible that Vi-expression may occur within CD-
18 cells.  However, no studies have definitely shown the exact cells types in which Vi-
expression occurs.  Our results illustrated that the Vi capsule was expressed following 
invasion of the gut mucosa, which supported a role of the capsule during bacterial host 
cell interaction in tissue.  This coincides with earlier calf ligated-ileal loop studies in 
which a capsulated S. Typhi reduced IL-17 expression in the bovine intestinal mucosa 
(82).  Our data along with the experimental findings from that study help to put forth the 
belief that Vi expression occurs after invasion and blocks the host immune system.  With 
previous data and our experimental findings in this chapter, the potential role of the Vi 
polysaccharide capsule and its regulated expression are summarized in Figure 19. 
Two distinct processes contribute to the hyperosmotic conditions within the 
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Figure 19.  Summary of events occurring within the gut lumen and gut-associated 
tissues with Salmonella typhi (Vi+) infection.  (1)  Exposure to the hyperosmotic 
conditions of the gut lumen upregulates SPI-1 and promotes a hyperinvasive phenotype.  
Vi-expression is down-regulated, which further contributes to increase secretion of SPI-1 
effectors. (2)  Salmonella typhi invades intestinal epithelial cells and induces IL-6 
secretion.  (3)  Exposure to the hypoosmotic conditions within tissue downregulates SPI-
1 and Vi-expression is upregulated.  (4) The invading bacteria are taken up by 
macrophages, dendritic cells (M cells), and lymphocytes within gut-associated tissue and 







enzymatically broken down into thousands of smaller molecules, each osmotically active 
and causing a dramatic increase in the osmolarity of the chyme.  Secondly, crypt cells 
actively secrete electrolytes into the lumen.  S. Typhi gains access to the intestinal lumen 
and is exposed to the hyperosmotic conditions, causing an up-regulation of SPI-1 (Type 
III secretion system) genes and the suppression of Vi antigen genes.  S. Typhi invades 
the intestinal mucosa and induces IL-6 secretion from intestinal epithelial cells.  After 
invasion, S. Typhi encounters hypoosmotic conditions within the tissue.  At this point, 
SPI-1 is down-regulated and Vi antigen expression is activated.  The expression of the 
Vi antigen in the lamina propria may be acting to mask PAMP recognition by 
phagocytes and preventing a TLR-mediated response.  This is consistent with the lack of 
IL-8 production and neutrophil recruitment seen with typhoid fever infections.  The 
invading bacteria are eventually taken up by macrophages, dendritic cells, and 
lymphocytes within the gut-associated lymphoid tissue and disseminated systemically.  
In the second chapter, we wanted to particularly study the involvement of the 
ompR regulon during invasion and its role in mediating Vi expression using human 
intestinal epithelial cells and the calf-ligated ileal loop model.  Salmonella Typhi 
possesses a functional invasion associated Type III secretion system (T3SS-1) important 
during the initial stages of infection of intestinal epithelial cells, similar to the 
mechanisms present in S. Typhimurium.  Recent studies have shown that that S. Typhi 
grown under conditions of high osmolarity in vitro switches off Vi antigen expression 
(78) whereas the type III secretion system genes become up-regulated (2).  The 
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mechanism by which this occurs still remains uncertain, though it appears that the 
expression of the Vi capsule and invasion-associated genes behave in an opposite 
manner.   Results from experiments with non-expressing Vi strains displayed increased 
invasion towards intestinal epithelial cells (71, 114).  These findings support the concept 
that Vi-suppressed and Vi mutant strains of S. Typhi promote an increased invasive 
phenotype, perhaps through the downregultion of Vi expression.  OmpR is a positive 
regulator in the synthesis and expression of the Vi capsule.  A single study reports that 
an ompR deletion in S. Typhi inhibits Vi production and the strain was not impaired in 
its ability to invade intestinal epithelial cells, but did not assess whether this strain 
displayed increased invasion (78).  As a result, we wanted to compare the invasiveness 
characteristics between S. Typhi grown under hyperosmotic conditions, a viaB mutant, 
and an ompR mutant.  We also wanted to determine the effects of these strains in 
eliciting inflammation in the calf model, a good animal model for studying typhoid fever 
pathogenesis.   
 We report that S. Typhi grown under Vi -suppressing conditions, the viaB 
mutant, and the ompR mutant all illustrated increase invasion in polarized T84 cells and 
bovine ileal tissue.  Analysis of invasion-associated genes encoded by SPI-1 with real 
time PCR also revealed increased levels of expression in fliC, iagA, prgH in the ompR 
mutant strain.  These data help to support our hypothesis that increased invasion among 
these strains may be due to the deficiency in Vi antigen expression and the regulation 
responsible for controlling SPI-7 and SPI-1 may function conversely.  The findings 
complement the theory that Vi expression maybe down-regulated in the intestinal lumen 
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in response to hyperosmotic stimuli in order to promote a hyperinvasive phenotype, 
allowing S. Typhi to invade deeper into tissues.   
Fluid accumulation in previous calf ligated-loop studies is observed as a marker 
of inflammation elicited by S. Typhimurium and S. Typhi as it corresponds to the 
number of bacteria that have invaded the gut mucosa (82-84).  The viaB mutant was 
previously demonstrated to have more fluid accumulation relative to the wild-type S. 
Typhi capsulated strain and similar levels of fluid accumulation to a S. Typhimurium 
capsule-expressing strain, once more suggesting the presence of the capsule may be 
responsible for inhibiting inflammation (82).  Fluid accumulation in loops inoculated in 
this investigation with Vi-deficient and Vi-suppressed strains were comparable to S. 
Typhimurium and were significantly higher than the LBH uninfected control loop.  This 
indicates the number of bacteria that invaded were comparable among the different 
strains.  Interestingly, all the S. Typhi strains used were Vi-lacking and S. Typhimurium 
does not possess a Vi capsule, providing a potential rationale for the increase invasion 
among Vi negative strains.  Histopathological evaluation of ileal tissue has also been 
performed to characterize inflammation induced by S. Typhimurium and S. Typhi in 
earlier experiments (82, 90).  The S. Typhi viaB mutant (STY2) has been shown to 
trigger more inflammation than its capsulated wild-type (82).  The histopathological 
inflammatory lesions produced in this study by the Vi-deficient and suppressed strains 
were quite similar.  The strains appear to elicit more inflammation than the capsulated 
strain.  Our data further supports the notion that Vi- suppressed and Vi mutants of S. 
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Figure 20.  Summary of events occurring within the gut lumen and gut-associated 
tissues with Salmonella typhi (Vi-) infections. (1)  Exposure to the hyperosmotic 
conditions of the gut lumen upregulates SPI-1 and promotes a hyperinvasive phenotype. 
The lack of Vi expression further contributes to increase secretion of SPI-1 effectors. (2)  
Salmonella invades intestinal epithelial cells and PAMPs are recognized by TLRs on the 
basolateral surface and induces IL-8 secretion.  (3) Salmonella continues to express SPI-
1 after encountering hyposmotic conditions in tissue.  (4) IL-8 recruits neutrophils to the 








mechanistically through the inactivation of the Vi antigen.  With previous reports and 
our experimental findings in this chapter, the characteristics of the Vi negative strains 
and their regulated expression are portrayed in Figure 20. 
In summary, the non-capsulated S. Typhi strains are exposed to the hyperosmotic 
conditions within the intestinal lumen.  Subsequently, the SPI-1 (T3SS-1) genes are 
upregulated and allow increased invasion.  Following invasion, the Vi negative strains 
do not express a Vi capsule, so PAMPS are recognized by the innate immune system, 
including TLR5 and TLR4, stimulated by flagellin and LPS, respectively.  The bacteria 
are also recognized by a wide variety of other PAMP receptors located on phagocytes 
circulating in the lamina propria. Upon activation of the TLR response, neutrophils are 
recruited to the site of infection and IL-8 is secreted. 
Extensive investigation has been conducted to characterize the regulation of the 
Vi expression in vitro; however, studies have shown that the gene regulation in  
infected hosts can markedly differ from what has been expected based on in vitro and 
cell culture work (5, 55, 56) stressing the need for in vivo studies to understand 
Salmonella virulence gene regulation fully. 
 Polysaccharide capsules are found on the surface of a wide range of gram-
negative bacteria.  Capsules have a significant role in determining access of certain 
molecules to the cell membrane, mediating adherence to surfaces, and increasing 
tolerance of desiccation. Furthermore, capsules of many pathogenic bacteria impair 
phagocytosis (63) and reduce the action of complement-mediated killing.  Consistent 
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with this belief, the Vi-antigen was shown to impede uptake of S. Typhi by human 
neutrophils (64).  Thus, the Vi capsular antigen is likely to be major virulence 
determinant of S. Typhi.  With this concept in mind, continued efforts should 
concentrate on the investigation of novel role(s) that the Vi-antigen may serve and the 





















1. Alves, G. E. S., S.M. Hartsfield, G.L. Carroll, S. Zhang, R.M. Tsolis, A.J. 
Baumler, L.G. Adams. 2003. Use of propofol, isoflurane and morphine for 
prolonged anesthesia in calves. Arq. Bras. Med. Vet. Zoo. 55:411-420. 
 
2. Arricau, N., D. Hermant, H. Waxin, C. Ecobichon, P. S. Duffey, and M. Y. 
Popoff. 1998. The RcsB-RcsC regulatory system of Salmonella typhi 
differentially modulates the expression of invasion proteins, flagellin and Vi 
antigen in response to osmolarity. Mol Microbiol 29:835-850. 
 
3. Arya, S. C. 2002. Field effectiveness of Vi polysaccharide typhoid vaccine in the 
People's Republic of China. J Infect Dis 185:845; author reply 845-846. 
 
4. Bernardini, M. L., A. Fontaine, and P. J. Sansonetti. 1990. The two-
component regulatory system ompR-envZ controls the virulence of Shigella 
flexneri. J Bacteriol 172:6274-6281. 
 
5. Beuzon, C. R., K. E. Unsworth, and D. W. Holden. 2001. In vivo genetic 
analysis indicates that PhoP-PhoQ and the Salmonella pathogenicity island 2 
type III secretion system contribute independently to Salmonella enterica serovar 
Typhimurium virulence. Infect Immun 69:7254-7261. 
 
6. Bhan, M. K., R. Bahl, and S. Bhatnagar. 2005. Typhoid and paratyphoid fever. 
Lancet 366:749-762. 
 
7. Bitar, R., and J. Tarpley. 1985. Intestinal perforation in typhoid fever: a 
historical and state-of-the-art review. Rev Infect Dis 7:257-271. 
 
8. Black, R. E., M. M. Levine, C. Ferreccio, M. L. Clements, C. Lanata, J. 
Rooney, and R. Germanier. 1990. Efficacy of one or two doses of Ty21a 
Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. 
Chilean Typhoid Committee. Vaccine 8:81-84. 
 
9. Bongaerts, R. J., I. Hautefort, J. M. Sidebotham, and J. C. Hinton. 2002. 
Green fluorescent protein as a marker for conditional gene expression in bacterial 
cells. Methods Enzymol 358:43-66. 
 
10. Bueno, S. M., C. A. Santiviago, A. A. Murillo, J. A. Fuentes, A. N. Trombert, 
P. I. Rodas, P. Youderian, and G. C. Mora. 2004. Precise excision of the large 
pathogenicity island, SPI7, in Salmonella enterica serovar Typhi. J Bacteriol 
186:3202-3213. 
 104
11. Bumann, D. 2002. Examination of Salmonella gene expression in an infected 
mammalian host using the green fluorescent protein and two-colour flow 
cytometry. Mol Microbiol 43:1269-1283. 
 
12. Cario, E., I. M. Rosenberg, S. L. Brandwein, P. L. Beck, H. C. Reinecker, 
and D. K. Podolsky. 2000. Lipopolysaccharide activates distinct signaling 
pathways in intestinal epithelial cell lines expressing Toll-like receptors. J 
Immunol 164:966-972. 
 
13. Carter, P. B., and F. M. Collins. 1974. The route of enteric infection in normal 
mice. J Exp Med 139:1189-1203. 
 
14. Clark, M. A., B. H. Hirst, and M. A. Jepson. 1998. Inoculum composition and 
Salmonella pathogenicity island 1 regulate M-cell invasion and epithelial 
destruction by Salmonella typhimurium. Infect Immun 66:724-731. 
 
15. Collins, F. M. 1972. Salmonellosis in orally infected specific pathogen-free 
C57B1 mice. Infect Immun 5:191-198. 
 
16. Cryz, S. J., Jr., N. Vanprapar, U. Thisyakorn, T. Olanratmanee, G. 
Losonsky, M. M. Levine, and S. Chearskul. 1993. Safety and immunogenicity 
of Salmonella typhi Ty21a vaccine in young Thai children. Infect Immun 
61:1149-1151. 
 
17. Daigle, F., J. E. Graham, and R. Curtiss, III. 2001. Identification of 
Salmonella typhi genes expressed within macrophages by selective capture of 
transcribed sequences (SCOTS). Mol Microbiol 41:1211-1222. 
 
18. Dalton, R. 1967. The effect of starvation on the fluid and electrolyte metabolism 
of neonatal calves. British Veterinary Journal 123:237-245. 
 
19. Day, D. W., B.K. Mandal, and B.C. Morson. 1978. The rectal biposy 
appearances in Salmonella colitis. Histopathology 2:117--131. 
 
20. Dharmsathaphorn, K., J. A. McRoberts, K. G. Mandel, L. D. Tisdale, and H. 
Masui. 1984. A human colonic tumor cell line that maintains vectorial 
electrolyte transport. Am J Physiol 246:G204-208. 
 
21. Dragunsky, E. M., C. R. Wooden, S. A. Vargo, and I. S. Levenbook. 1989. 
Salmonella typhi vaccine strain in vitro; low infectivity in human cell line U937. 




22. Edsall, G., S. Gaines, M. Landy, W. D. Tigertt, H. Sprinz, R. J. Trapani, A. 
D. Mandel, and A. S. Benenson. 1960. Studies on infection and immunity in 
experimental typhoid fever. I. Typhoid fever in chimpanzees orally infected with 
Salmonella typhosa. J Exp Med 112:143-166. 
 
23. Eriksson, S., S. Lucchini, A. Thompson, M. Rhen, and J. C. Hinton. 2003. 
Unravelling the biology of macrophage infection by gene expression profiling of 
intracellular Salmonella enterica. Mol Microbiol 47:103-118. 
 
24. Faucher, S. P., R. Curtiss, III, and F. Daigle. 2005. Selective capture of 
Salmonella enterica serovar typhi genes expressed in macrophages that are 
absent from the Salmonella enterica serovar Typhimurium genome. Infect 
Immun 73:5217-5221. 
 
25. Faucher, S. P., S. Porwollik, C. M. Dozois, M. McClelland, and F. Daigle. 
2006. Transcriptome of Salmonella enterica serovar Typhi within macrophages 
revealed through the selective capture of transcribed sequences. Proc Natl Acad 
Sci U S A 103:1906-1911. 
 
26. Finlay, B. B. 1994. Molecular and cellular mechanisms of Salmonella 
pathogenesis. Curr Top Microbiol Immunol 192:163-185. 
 
27. Fordtran, J. S., F. C. Rector, Jr., M. F. Ewton, N. Soter, and J. Kinney. 
1965. Permeability characteristics of the human small intestine. J Clin Invest 
44:1935-1944. 
 
28. Gaines, S., H. Sprinz, J. G. Tully, and W. D. Tigertt. 1968. Studies on 
infection and immunity in experimental typhoid fever. VII. The distribution of 
Salmonella typhi in chimpanzee tissue following oral challenge, and the 
relationship between the numbers of bacilli and morphologic lesions. J Infect Dis 
118:293-306. 
 
29. Galan, J. E. 2001. Salmonella interactions with host cells: type III secretion at 
work. Annu Rev Cell Dev Biol 17:53-86. 
 
30. Galan, J. E., and R. Curtiss, III. 1989. Cloning and molecular characterization 
of genes whose products allow Salmonella typhimurium to penetrate tissue 
culture cells. Proc Natl Acad Sci U S A 86:6383-6387. 
 
31. Gewirtz, A. T., T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara. 
2001. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to 
induce epithelial proinflammatory gene expression. J Immunol 167:1882-1885. 
 
 106
32. Gupta, S., and R. Chowdhury. 1997. Bile affects production of virulence 
factors and motility of Vibrio cholerae. Infect Immun 65:1131-1134. 
 
33. Hallback, D. A., M. Jodal, and O. Lundgren. 1980. Villous tissue osmolality, 
water and electrolyte transport in the cat small intestine at varying luminal 
osmolalities. Acta Physiol Scand 110:95-100. 
 
34. Hallback, D. A., M. Jodal, A. Sjoqvist, and O. Lundgren. 1979. Villous tissue 
osmolality and intestinal transport of water and electrolytes. Acta Physiol Scand 
107:115-126. 
 
35. Hansen-Wester, I., and M. Hensel. 2001. Salmonella pathogenicity islands 
encoding type III secretion systems. Microbes Infect 3:549-559. 
 
36. Harris, J. C., H. L. Dupont, and R. B. Hornick. 1972. Fecal leukocytes in 
diarrheal illness. Ann Intern Med 76:697-703. 
 
37. Hashimoto, Y., A. Q. Khan, and T. Ezaki. 1996. Positive autoregulation of 
vipR expression in ViaB region-encoded Vi antigen of Salmonella typhi. J 
Bacteriol 178:1430-1436. 
 
38. Hashimoto, Y., N. Li, H. Yokoyama, and T. Ezaki. 1993. Complete nucleotide 
sequence and molecular characterization of ViaB region encoding Vi antigen in 
Salmonella typhi. J Bacteriol 175:4456-4465. 
 
39. Hautefort, I., A. Thompson, S. Eriksson-Ygberg, M. L. Parker, S. Lucchini, 
V. Danino, R. J. Bongaerts, N. Ahmad, M. Rhen, and J. C. Hinton. 2008. 
During infection of epithelial cells Salmonella enterica serovar Typhimurium 
undergoes a time-dependent transcriptional adaptation that results in 
simultaneous expression of three type 3 secretion systems. Cell Microbiol 
10:958-984. 
 
40. Hessel, L., H. Debois, M. Fletcher, and R. Dumas. 1999. Experience with 
Salmonella typhi Vi capsular polysaccharide vaccine. Eur J Clin Microbiol Infect 
Dis 18:609-620. 
 
41. Heyns, K. a. G. K. 1967. Strukturafklarung des Vi-antigens aus Citrobacter 
freundii (E.coli) 5396/38. Carbohydr. Res. 3:340-353. 
 
42. Hirose, K., T. Ezaki, M. Miyake, T. Li, A. Q. Khan, Y. Kawamura, H. 
Yokoyama, and T. Takami. 1997. Survival of Vi-capsulated and Vi-deleted 
Salmonella typhi strains in cultured macrophage expressing different levels of 
CD14 antigen. FEMS Microbiol Lett 147:259-265. 
 107
43. Hone, D. M., S. R. Attridge, B. Forrest, R. Morona, D. Daniels, J. T. 
LaBrooy, R. C. Bartholomeusz, D. J. Shearman, and J. Hackett. 1988. A 
galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence 
in humans. Infect Immun 56:1326-1333. 
 
44. Hornick, R. B., S. E. Greisman, T. E. Woodward, H. L. DuPont, A. T. 
Dawkins, and M. J. Snyder. 1970. Typhoid fever: pathogenesis and 
immunologic control. N Engl J Med 283:686-691. 
 
45. Ishibashi, Y., and T. Arai. 1995. Salmonella typhi does not inhibit phagosome-
lysosome fusion in human monocyte-derived macrophages. FEMS Immunol Med 
Microbiol 12:55-61. 
 
46. Ishibashi, Y., and T. Arai. 1996. A possible mechanism for host-specific 
pathogenesis of Salmonella serovars. Microb Pathog 21:435-446. 
 
 
47. Jodal, M., and O. Lundgren. 1986. Countercurrent mechanisms in the 
mammalian gastrointestinal tract. Gastroenterology 91:225-241. 
 
48. Khan, S. A., P. Everest, S. Servos, N. Foxwell, U. Zahringer, H. Brade, E. T. 
Rietschel, G. Dougan, I. G. Charles, and D. J. Maskell. 1998. A lethal role for 
lipid A in Salmonella infections. Mol Microbiol 29:571-579. 
 
49. Klugman, K. P., I. T. Gilbertson, H. J. Koornhof, J. B. Robbins, R. 
Schneerson, D. Schulz, M. Cadoz, and J. Armand. 1987. Protective activity of 
Vi capsular polysaccharide vaccine against typhoid fever. Lancet 2:1165-1169. 
 
50. Klugman, K. P., H. J. Koornhof, J. B. Robbins, and N. N. Le Cam. 1996. 
Immunogenicity, efficacy and serological correlate of protection of Salmonella 
typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 
14:435-438. 
 
51. Kohbata, S., H. Yokoyama, and E. Yabuuchi. 1986. Cytopathogenic effect of 
Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in 
ligated ileal loops: an ultrastructural study. Microbiol Immunol 30:1225-1237. 
 
52. Kollaritsch, H., J. U. Que, C. Kunz, G. Wiedermann, C. Herzog, and S. J. 
Cryz, Jr. 1997. Safety and immunogenicity of live oral cholera and typhoid 
vaccines administered alone or in combination with antimalarial drugs, oral polio 





53. Kraus, M. D., B. Amatya, and Y. Kimula. 1999. Histopathology of typhoid 
enteritis: morphologic and immunophenotypic findings. Mod Pathol 12:949-955. 
 
54. Lee, F. K., C. Morris, and J. Hackett. 2006. The Salmonella enterica serovar 
Typhi Vi capsule and self-association pili share controls on expression. FEMS 
Microbiol Lett 261:41-46. 
 
55. Lee, S. H., and A. Camilli. 2000. Novel approaches to monitor bacterial gene 
expression in infected tissue and host. Curr Opin Microbiol 3:97-101. 
 
56. Lee, S. H., D. L. Hava, M. K. Waldor, and A. Camilli. 1999. Regulation and 
temporal expression patterns of Vibrio cholerae virulence genes during infection. 
Cell 99:625-634. 
 
57. Levine, M. M., C. Ferreccio, P. Abrego, O. S. Martin, E. Ortiz, and S. Cryz. 
1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral 
vaccine. Vaccine 17 Suppl 2:S22-27. 
 
58. Levine, M. M., C. Ferreccio, R. E. Black, and R. Germanier. 1987. Large-
scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule 
formulation. Lancet 1:1049-1052. 
 
59. Levine, M. M., C. Ferreccio, S. Cryz, and E. Ortiz. 1990. Comparison of 
enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in 
randomised controlled field trial. Lancet 336:891-894. 
 
60. Levine, M. M., C. O. Tacket, and M. B. Sztein. 2001. Host-Salmonella 
interaction: human trials. Microbes Infect 3:1271-1279. 
 
61. Levy, M., A. M. Merritt, and L. C. Levy. 1990. Comparison of the effects of an 
isosmolar and hyperosmolar oral rehydrating solution on the hydration status, 
glycemia and ileal content composition of healthy neonatal calves. Cornell Vet 
80:143-151. 
 
62. Lin, F. Y., V. A. Ho, H. B. Khiem, D. D. Trach, P. V. Bay, T. C. Thanh, Z. 
Kossaczka, D. A. Bryla, J. Shiloach, J. B. Robbins, R. Schneerson, and S. C. 
Szu. 2001. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-
five-year-old children. N Engl J Med 344:1263-1269. 
 
63. Lindberg, A. A. 1999. Polyosides (encapsulated bacteria). C R Acad Sci III 
322:925-932. 
 
64. Looney, R. J., and R. T. Steigbigel. 1986. Role of the Vi antigen of Salmonella 
typhi in resistance to host defense in vitro. J Lab Clin Med 108:506-516. 
 109
65. McCormick, B. A., A. M. Siber, and A. T. Maurelli. 1998. Requirement of the 
Shigella flexneri virulence plasmid in the ability to induce trafficking of 
neutrophils across polarized monolayers of the intestinal epithelium. Infect 
Immun 66:4237-4243. 
 
66. McGovern, V. J., and L. J. Slavutin. 1979. Pathology of Salmonella colitits. 
Am J Surg Oathol 3:483-490. 
 
67. McKenna, A. J., J. A. Bygraves, M. C. Maiden, and I. M. Feavers. 1995. 
Attenuated typhoid vaccine Salmonella typhi Ty21a: fingerprinting and quality 
control. Microbiology 141 ( Pt 8):1993-2002. 
 
68. Merican, I. 1997. Typhoid fever: present and future. Med J Malaysia 52:299-
308; quiz 309. 
 
69. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in 
construction of insertion mutations: osmoregulation of outer membrane proteins 
and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 
170:2575-2583. 
 
70. Mishra, A., R. Srivastava, C. Pruzzo, and B. S. Srivastava. 2003. Mutation in 
tcpR gene (Vc0832) of Vibrio cholerae O1 causes loss of tolerance to high 
osmolarity and affects colonization and virulence in infant mice. J Med 
Microbiol 52:933-939. 
 
71. Miyake, M., L. Zhao, T. Ezaki, K. Hirose, A. Q. Khan, Y. Kawamura, R. 
Shima, M. Kamijo, T. Masuzawa, and Y. Yanagihara. 1998. Vi-deficient and 
nonfimbriated mutants of Salmonella typhi agglutinate human blood type 
antigens and are hyperinvasive. FEMS Microbiol Lett 161:75-82. 
 
72. Murphy, J. R., L. Grez, L. Schlesinger, C. Ferreccio, S. Baqar, C. Munoz, S. 
S. Wasserman, G. Losonsky, J. G. Olson, and M. M. Levine. 1991. 
Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect 
Immun 59:4291-4293. 
 
73. Nair, S., S. Alokam, S. Kothapalli, S. Porwollik, E. Proctor, C. Choy, M. 
McClelland, S. L. Liu, and K. E. Sanderson. 2004. Salmonella enterica 
serovar Typhi strains from which SPI7, a 134-kilobase island with genes for Vi 
exopolysaccharide and other functions, has been deleted. J Bacteriol 186:3214-
3223. 
 
74. Pang, T., M. M. Levine, B. Ivanoff, J. Wain, and B. B. Finlay. 1998. Typhoid 
fever--important issues still remain. Trends Microbiol 6:131-133. 
 
 110
75. Paniker, C. K., and K. N. Vimala. 1972. Transferable chloramphenicol 
resistance in Salmonella typhi. Nature 239:109-110. 
 
76. Parkhill, J., G. Dougan, K. D. James, N. R. Thomson, D. Pickard, J. Wain, 
C. Churcher, K. L. Mungall, S. D. Bentley, M. T. Holden, M. Sebaihia, S. 
Baker, D. Basham, K. Brooks, T. Chillingworth, P. Connerton, A. Cronin, P. 
Davis, R. M. Davies, L. Dowd, N. White, J. Farrar, T. Feltwell, N. Hamlin, 
A. Haque, T. T. Hien, S. Holroyd, K. Jagels, A. Krogh, T. S. Larsen, S. 
Leather, S. Moule, P. O'Gaora, C. Parry, M. Quail, K. Rutherford, M. 
Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrell. 2001. 
Complete genome sequence of a multiple drug resistant Salmonella enterica 
serovar Typhi CT18. Nature 413:848-852. 
 
77. Pascopella, L., B. Raupach, N. Ghori, D. Monack, S. Falkow, and P. L. 
Small. 1995. Host restriction phenotypes of Salmonella typhi and Salmonella 
gallinarum. Infect Immun 63:4329-4335. 
 
78. Pickard, D., J. Li, M. Roberts, D. Maskell, D. Hone, M. Levine, G. Dougan, 
and S. Chatfield. 1994. Characterization of defined ompR mutants of Salmonella 
typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect 
Immun 62:3984-3993. 
 
79. Puente, J. L., A. Verdugo-Rodriguez, and E. Calva. 1991. Expression of 
Salmonella typhi and Escherichia coli OmpC is influenced differently by 
medium osmolarity; dependence on Escherichia coli OmpR. Mol Microbiol 
5:1205-1210. 
 
80. Raffatellu, M., D. Chessa, R. P. Wilson, R. Dusold, S. Rubino, and A. J. 
Baumler. 2005. The Vi capsular antigen of Salmonella enterica serotype Typhi 
reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal 
mucosa. Infect Immun 73:3367-3374. 
 
81. Raffatellu, M., D. Chessa, R. P. Wilson, C. Tukel, M. Akcelik, and A. J. 
Baumler. 2006. Capsule-mediated immune evasion: a new hypothesis explaining 
aspects of typhoid fever pathogenesis. Infect Immun 74:19-27. 
 
82. Raffatellu, M., R. L. Santos, D. Chessa, R. P. Wilson, S. E. Winter, C. A. 
Rossetti, S. D. Lawhon, H. Chu, T. Lau, C. L. Bevins, L. G. Adams, and A. J. 
Baumler. 2007. The capsule encoding the viaB locus reduces interleukin-17 
expression and mucosal innate responses in the bovine intestinal mucosa during 




83. Raffatellu, M., Y. H. Sun, R. P. Wilson, Q. T. Tran, D. Chessa, H. L. 
Andrews-Polymenis, S. D. Lawhon, J. F. Figueiredo, R. M. Tsolis, L. G. 
Adams, and A. J. Baumler. 2005. Host restriction of Salmonella enterica 
serotype Typhi is not caused by functional alteration of SipA, SopB, or SopD. 
Infect Immun 73:7817-7826. 
 
84. Raffatellu, M., R. P. Wilson, D. Chessa, H. Andrews-Polymenis, Q. T. Tran, 
S. Lawhon, S. Khare, L. G. Adams, and A. J. Baumler. 2005. SipA, SopA, 
SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium 
invasion of epithelial cells. Infect Immun 73:146-154. 
 
85. Robbins, J. D., and J. B. Robbins. 1984. Reexamination of the protective role 
of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 
150:436-449. 
 
86. Rowe, B., L. R. Ward, and E. J. Threlfall. 1997. Multidrug-resistant 
Salmonella typhi: a worldwide epidemic. Clin Infect Dis 24 Suppl 1:S106-109. 
 
87. Saha, M. R., T. Ramamurthy, P. Dutta, and U. Mitra. 2000. Emergence of 
Salmonella typhi Vi antigen-negative strains in an epidemic of multidrug-
resistant typhoid fever cases in Calcutta, India. Natl Med J India 13:164. 
 
88. Santander, J., S. Y. Wanda, C. A. Nickerson, and R. Curtiss, III. 2007. Role 
of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella 
enterica serotype Typhi. Infect Immun 75:1382-1392. 
 
89. Santos, R. L., R. M. Tsolis, S. Zhang, T. A. Ficht, A. J. Baumler, and L. G. 
Adams. 2001. Salmonella-induced cell death is not required for enteritis in 
calves. Infect Immun 69:4610-4617. 
 
90. Santos, R. L., S. Zhang, R. M. Tsolis, R. A. Kingsley, L. G. Adams, and A. J. 
Baumler. 2001. Animal models of Salmonella infections: enteritis versus 
typhoid fever. Microbes Infect 3:1335-1344. 
 
91. Shirai, Y., K. Sunakawa, Y. Ichihashi, and H. Yamaguchi. 1979. A 
morphological study in germfree mice (Salmonella infection). Exp Pathol (Jena) 
17:158-166. 
 
92. Spalding, D. M., W. J. Koopman, J. H. Eldridge, J. R. McGhee, and R. M. 
Steinman. 1983. Accessory cells in murine Peyer's patch. I. Identification and 
enrichment of a functional dendritic cell. J Exp Med 157:1646-1659. 
 
 112
93. Spalding, D. M., S. I. Williamson, J. R. McGhee, and W. J. Koopman. 1984. 
Peyer's patch dendritic cells: isolation and functional comparison with murine 
spleen dendritic cells. Immunobiology 168:380-390. 
 
94. Sprinz, H., E.J. Gangarosa, M. Williams, R. B. Hornick, and T. E. 
Woodward. 1966. Histopathology of the upper small intestines in typhoid fever.  
Biopsy study of experimental disease in man. Am J Dig Dis 11:615-624. 
 
95. Streng, W. H., H. E. Huber, and J. T. Carstensen. 1978. Relationship between 
osmolality and osmolarity. J Pharm Sci 67:384-386. 
 
96. Tacket, C. O., G. Losonsky, D. N. Taylor, L. S. Baron, D. Kopecko, S. Cryz, 
and M. M. Levine. 1991. Lack of immune response to the Vi component of a 
Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in 
human studies. J Infect Dis 163:901-904. 
 
97. Tartera, C., and E. S. Metcalf. 1993. Osmolarity and growth phase overlap in 
regulation of Salmonella typhi adherence to and invasion of human intestinal 
cells. Infect Immun 61:3084-3089. 
 
98. Tsolis, R. M., L. G. Adams, T. A. Ficht, and A. J. Baumler. 1999. 
Contribution of Salmonella typhimurium virulence factors to diarrheal disease in 
calves. Infect Immun 67:4879-4885. 
 
99. Tsolis, R. M., L. G. Adams, M. J. Hantman, C. A. Scherer, T. Kimbrough, 
R. A. Kingsley, T. A. Ficht, S. I. Miller, and A. J. Baumler. 2000. SspA is 
required for lethal Salmonella enterica serovar Typhimurium infections in calves 
but is not essential for diarrhea. Infect Immun 68:3158-3163. 
 
100. Valdivia, R. H., and S. Falkow. 1996. Bacterial genetics by flow cytometry: 
rapid isolation of Salmonella typhimurium acid-inducible promoters by 
differential fluorescence induction. Mol Microbiol 22:367-378. 
 
101. Valdivia, R. H., A. E. Hromockyj, D. Monack, L. Ramakrishnan, and S. 
Falkow. 1996. Applications for green fluorescent protein (GFP) in the study of 
host-pathogen interactions. Gene 173:47-52. 
 
102. Vazquez-Torres, A., J. Jones-Carson, A. J. Baumler, S. Falkow, R. Valdivia, 
W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. 




103. Virlogeux, I., H. Waxin, C. Ecobichon, J. O. Lee, and M. Y. Popoff. 1996. 
Characterization of the rcsA and rcsB genes from Salmonella typhi: rcsB through 
tviA is involved in regulation of Vi antigen synthesis. J Bacteriol 178:1691-1698. 
 
104. Virlogeux, I., H. Waxin, C. Ecobichon, and M. Y. Popoff. 1995. Role of the 
viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. 
Microbiology 141 ( Pt 12):3039-3047. 
 
105. Wahdan, M. H., C. Serie, Y. Cerisier, S. Sallam, and R. Germanier. 1982. A 
controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against 
typhoid: three-year results. J Infect Dis 145:292-295. 
 
106. Wain, J., and C. Kidgell. 2004. The emergence of multidrug resistance to 
antimicrobial agents for the treatment of typhoid fever. Trans R Soc Trop Med 
Hyg 98:423-430. 
 
107. Weinstein, D. L., B. L. O'Neill, and E. S. Metcalf. 1997. Salmonella typhi 
stimulation of human intestinal epithelial cells induces secretion of epithelial 
cell-derived interleukin-6. Infect Immun 65:395-404. 
 
108. World Health Organization. Geneva, Switzerland. 1996. The world health 
report 1996:  fighting disease fostering development.  
 
109. Wray, C., and W. J. Sojka. 1978. Experimental Salmonella typhimurium 
infection in calves. Res Vet Sci 25:139-143. 
 
110. Zhang, S., L. G. Adams, J. Nunes, S. Khare, R. M. Tsolis, and A. J. Baumler. 
2003. Secreted effector proteins of Salmonella enterica serotype typhimurium 
elicit host-specific chemokine profiles in animal models of typhoid fever and 
enterocolitis. Infect Immun 71:4795-4803. 
 
111. Zhang, S., R. A. Kingsley, R. L. Santos, H. Andrews-Polymenis, M. 
Raffatellu, J. Figueiredo, J. Nunes, R. M. Tsolis, L. G. Adams, and A. J. 
Baumler. 2003. Molecular pathogenesis of Salmonella enterica serotype 
typhimurium-induced diarrhea. Infect Immun 71:1-12. 
 
112. Zhang, S., R. L. Santos, R. M. Tsolis, S. Mirold, W. D. Hardt, L. G. Adams, 
and A. J. Baumler. 2002. Phage mediated horizontal transfer of the sopE1 gene 
increases enteropathogenicity of Salmonella enterica serotype Typhimurium for 





113. Zhang, X. L., I. S. Tsui, C. M. Yip, A. W. Fung, D. K. Wong, X. Dai, Y. 
Yang, J. Hackett, and C. Morris. 2000. Salmonella enterica serovar typhi uses 
type IVB pili to enter human intestinal epithelial cells. Infect Immun 68:3067-
3073. 
 
114. Zhao, L., T. Ezak, Z. Y. Li, Y. Kawamura, K. Hirose, and H. Watanabe. 
2001. Vi-Suppressed wild strain Salmonella typhi cultured in high osmolarity is 
hyperinvasive toward epithelial cells and destructive of Peyer's patches. 







































HISTOLOGY SLIDES FROM THE INOCULATION OF  






Figure A-1.  H&E stain of bovine intestinal epithelium (ileum) from calf# 2, 8 hours 
post-inoculation with S. Typhi Ty2 viaB mutant.  The tissue exhibits moderate blunting, 
erosion, and epithelial detachment, with moderate neutrophilic and mononuclear 
infiltration.  Some luminal necrotic debris containing neutrophils and fibrin present in 




















Figure A-2.  H&E stain of bovine intestinal epithelium (ileum) from calf# 2, 8 hours 
post-inoculation with S. Typhi wild type Ty2 grown in LB broth.  The tissue exhibits 
mild blunting and epithelial detachment, with a mild neutrophilic and mononuclear 
































Figure A-3.  H&E stain of bovine intestinal epithelium (ileum) from calf# 2, 8 hours 
post-inoculation with S. Typhimurium wild type (IR715).  The tissue exhibits severe 
blunting, erosion, and epithelial detachment, with a moderate neutrophilic and 
mononuclear infiltration. The endothelium is reactive and possesses marginating 































Figure A-4.  H&E stain of bovine intestinal epithelium (ileum) from calf# 3, 8 hours 
post-inoculation with S. Typhi Ty2 wild type grown in LBH broth.  The tissue exhibits 
moderate blunting, erosion, and epithelial detachment, with a mild neutrophilic and 





























Figure A-5.  H&E stain of bovine intestinal epithelium (ileum) from calf# 1, 8 hours 
post-inoculation with S. Typhi Ty2 wild type grown in LBH broth.  The tissue exhibits 
moderate blunting, erosion, and epithelial detachment, with a mild neutrophilic and 
mononuclear infiltration.  Margination of neutrophils in the submucosal blood vessels 
and transmigration of neutrophils over the dome villi.  Early crypt abscess formation is 

































Figure A-6.  H&E stain of bovine intestinal epithelium (ileum) from calf# 1, post-
inoculation with S. Typhi Ty2 grown in LBH broth.  The tissue exhibits severe blunting, 
erosion, and epithelial detachment, with a moderate neutrophilic and mild mononuclear 




























Figure A-7.  H&E stain of bovine intestinal epithelium (ileum) from calf# 2, post-
inoculation with S. Typhi Ty2 grown in LB broth.  The tissue exhibits mild blunting, 
erosion, and epithelial detachment, with a mild neutrophilic and mononuclear 
infiltration.  Plugs of neutrophils within the submucosa of thin-walled vessels.  
Neutrophils and globular leukocytes inside lacteals.  Presence of reactive endothelium 










Figure A-8.  H&E stain of bovine intestinal epithelium (ileum) from calf# 1, 8 hours 
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